Not financial advice. All signals are advisory only. No position sizing recommendation here constitutes an order or instruction to trade. Verify all data independently before making any investment decision.
Top 3 to Buy
No signals of this type today.
Top 3 to Sell
AEP — conviction 0.95
Why: The investment case for AEP is rejected based on a lack of margin of safety and deteriorating fundamental indicators. The stock’s current price of 127.14 significantly exceeds the Graham Number of 87.4669, indicating a premium over conservative intrinsic value. This is compounded by a very low Value score of 1.67 and a Piotroski F-score of 1, which signals poor financial health and deteriorating fundamentals. The News digest showed neutral sentiment (0.0) across 7 articles, providing no positive catalysts to offset the poor valuation metrics. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, but this does not override the clear evidence of over-valuation and weak fundamentals. The prior review also confirmed a ‘Fail’ with 0.85 conviction and 0% margin of safety.
Key Risks: Significant over-valuation relative to Graham Number (127.14 vs 87.4669); Poor financial health as indicated by a Piotroski F-score of 1; Low Value score of 1.67/10; High macro-risk exposure (GPR percentile 89.82)
AERT — conviction 0.95
Why: AERT is identified as a classic ‘value trap.’ While the Margin of Safety is high (69.82%), this is heavily outweighed by the critically low Piotroski F-score of 1, which indicates severe fundamental deterioration in profitability and financial health. The ‘risk_off’ macro regime (GPR percentile 89.82) and the Industrials sector classification create a challenging environment for a stock with such poor quality metrics. The News Digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental decay. The prior review also confirmed a ‘Fail’ with high conviction (0.95), suggesting the issues are structural rather than transitory.
Key Risks: Piotroski F-score of 1 indicates extreme fundamental weakness; High risk of a ‘value trap’ where low price reflects deteriorating fundamentals; Unfavorable ‘risk_off’ macro regime for the Industrials sector; Low Value score (2.92) indicating poor market perception of quality
AES — conviction 0.95
Why: The investment case for AES is fundamentally undermined by a critical lack of financial health, as evidenced by a Piotroski F-score of 1. While the current price of 14.95 is below the Graham Number of 20.4039, the extremely low Value score of 2.26 indicates that the market does not view this as a high-quality value opportunity, but rather as a potential ‘value trap.’ The ‘risk_off’ macro regime (GPR_pct of 89.82) typically favors utilities, but this is negated by the deteriorating financial position and the lack of any positive sentiment or growth catalysts. The prior review also confirmed a ‘Fail’ with high conviction (0.95) and 0% Margin of Safety. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the poor fundamentals.
Key Risks: Critical financial deterioration (Piotroski F-score of 1); Low Value score (2.26) suggesting poor quality of underlying assets; Zero Margin of Safety (0%) as noted in prior review; Risk-off macro environment increasing scrutiny on debt and capital expenditure
Run Summary
- Started: 2026-10-19T10:30:00Z
- Finished: 2026-10-19T12:32:24Z
- Covered: 132 tickers
- Deferred (deadline): 68 tickers — CMPS, CNEY, CNM, CNOB, CNP, CODA, COGT, COLB, COP, COR, CPHC, CPSH, CPT, CRGO, CRNC, CRNT, CRTO, CTHH, CTNM, CTRE, CTS, CURI, CVNA, CW, CWD, CXDO, CXM, DAIO, DBCA, DDC, DEA, DFIN, DGP, DGXX, DGZ, DLPN, DLR, DPC, DRK, DSM, DUKU, DXC, ECCC, ECCU, ECF, ECOR, EE, EEA, EGAN, EHC, EIKN, EJH, ELA, ELVA, ENSG, ENTG, EONR, EPOW, EPRT, EQIX, ERAS, EVER, EVG, EVOX, EW, EXPD, FATE, FBIO
Signal Table
| Ticker | Action | Conviction | Current% | Target% | Δ% | Value | SmartMoney | Verdict | Staleness |
|---|---|---|---|---|---|---|---|---|---|
| ABAT | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| ACN | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CDT | HOLD | 0.40 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| ABUS | HOLD | 0.38 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| ABXL | HOLD | 0.35 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| BRK.B | HOLD | 0.35 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CMPS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CNEY | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CNM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CNOB | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| CNP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CODA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| COGT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| COLB | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.1 | +0.00 | Grey | 0d |
| COP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| COR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CPHC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.0 | +0.00 | Grey | 0d |
| CPSH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CPT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CRGO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CRNC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CRNT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| CRTO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| CTHH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CTNM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| CTRE | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| CTS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CURI | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CVNA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CW | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CWD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| CXDO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| CXM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DAIO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DBCA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DDC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DEA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.3 | +0.00 | Grey | 0d |
| DFIN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DGP | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DGXX | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DGZ | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DLPN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DLR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DPC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| DRK | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| DSM | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| DUKU | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| DXC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.5 | +0.00 | Grey | 0d |
| ECCC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.0 | +0.00 | Grey | 0d |
| ECCU | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| ECF | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| ECOR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EE | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.5 | +0.00 | Grey | 0d |
| EEA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| EGAN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.1 | +0.00 | Grey | 0d |
| EHC | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| EIKN | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| EJH | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.8 | +0.00 | Grey | 0d |
| ELA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 3.5 | +0.00 | Grey | 0d |
| ELVA | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| ENSG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| ENTG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| EONR | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| EPOW | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EPRT | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.5 | +0.00 | Grey | 0d |
| EQIX | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| ERAS | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EVER | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.5 | +0.00 | Grey | 0d |
| EVG | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 2.9 | +0.00 | Grey | 0d |
| EVOX | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.0 | +0.00 | Grey | 0d |
| EW | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 0.4 | +0.00 | Grey | 0d |
| EXPD | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.7 | +0.00 | Grey | 0d |
| FATE | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 1.2 | +0.00 | Grey | 0d |
| FBIO | HOLD | 0.00 | 0.0% | 0.0% | +0.0% | 4.2 | +0.00 | Grey | 0d |
| AEP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| AERT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AES | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| AESP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AEXA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AFJK | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AGIG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| AI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AIBZ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AIN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AIZN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AKR | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| ALGT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| ALHC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| ALTG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ALX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| AMBQ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AMCX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AMGN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| AMX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.5 | +0.00 | Fail | 0d |
| AOSL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| APG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| APOS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| APPS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| APUS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARBB | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| ARDC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| AROC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ARTC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARTV | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| ATHR | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ATOS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| ATR | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| AVX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| AXGN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AXP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| AZN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BANL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BANX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BBGI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BBNX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BEN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BGMS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| BH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BHB | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.8 | +0.00 | Fail | 0d |
| BHST | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BIRD | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| BIT | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BIVI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BIXI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BJRI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BKE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.5 | +0.00 | Fail | 0d |
| BKSY | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BMGL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BMHL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BMNP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BOLD | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BOOM | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BOXL | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BPYPO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| BRO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BSM | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.3 | +0.00 | Fail | 0d |
| BSP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| BTTC | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BTU | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BURU | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BXP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| BZAI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| BZH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CAAP | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.7 | +0.00 | Fail | 0d |
| CABA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CALY | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.1 | +0.00 | Fail | 0d |
| CART | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| CASH | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 3.4 | +0.00 | Fail | 0d |
| CBRE | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CCK | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| CCO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CDRO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CELZ | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CEPS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CEVA | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| CFND | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CHAI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CHCO | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CHD | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CHSCN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| CHY | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 4.2 | +0.00 | Fail | 0d |
| CIX | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CLFD | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CLGN | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CLLS | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.2 | +0.00 | Fail | 0d |
| CMG | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CMI | SELL | 0.95 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ACVA | SELL | 0.93 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| AFGE | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AFYA | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 5.4 | +0.00 | Fail | 0d |
| BBWI | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BCSF | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 4.2 | +0.00 | Fail | 0d |
| BF.A | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BID | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BSRR | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 4.0 | +0.00 | Fail | 0d |
| CBFV | SELL | 0.90 | 0.0% | 0.0% | -0.0% | 1.1 | +0.00 | Fail | 0d |
| AQST | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ARWR | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ASB | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| ATTT | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 3.8 | +0.00 | Fail | 0d |
| AURA | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BLK | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| BOX | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.9 | +0.00 | Fail | 0d |
| BVN | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 3.5 | +0.00 | Fail | 0d |
| BXMT | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.0 | +0.00 | Fail | 0d |
| BZ | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 3.8 | +0.00 | Fail | 0d |
| CACI | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CAE | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CAPL | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CCC | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| CHSCL | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.4 | +0.00 | Fail | 0d |
| CLPT | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| CMCSA | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 5.4 | +0.00 | Fail | 0d |
| CMCT | SELL | 0.85 | 0.0% | 0.0% | -0.0% | 2.5 | +0.00 | Fail | 0d |
| ACRE | SELL | 0.80 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ABSI | SELL | 0.70 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| ADAMO | SELL | 0.65 | 0.0% | 0.0% | -0.0% | 0.0 | +0.00 | Fail | 0d |
| AEM | SELL | 0.65 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
| ADAMH | SELL | 0.60 | 0.0% | 0.0% | -0.0% | 1.7 | +0.00 | Fail | 0d |
Signal Detail
ABAT — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: The news digest showed three positive headlines about export approval and a $100M Department of Commerce license for recycled black mass, with a sentiment score of +0.2929. However, coverage is narrow and event-driven, and does not alter the fundamental picture. The evidence bundle lacks financial statements (revenue, earnings, cash flow, balance sheet), leaving Piotroski F-score at 0, value score at 0.0, and margin of safety at -377.42% — all verbatim from the bundle. The macro regime is risk_off with GPR at the 89.82nd percentile, a headwind for speculative industrials. The prior review (2026-10-09) was Grey with 0.4 conviction and a -561% MoS. With insufficient data to assess earnings quality, moat, balance-sheet health, or cash runway, and with bear arguments (zero Piotroski, zero value score, deeply negative MoS) unrebutted, the setup remains speculative. A Grey verdict is warranted due to thin evidence and the rule that a single compelling bear argument not rebutted mandates at minimum Grey.
Key Risks: Deeply negative margin of safety (-377.42%); Piotroski F-score of 0 indicating severe fundamental deterioration; Value score of 0.0; Absence of financial statement data (revenue, earnings, cash flow, balance sheet); Macro regime risk_off with GPR percentile 89.82 (elevated geopolitical risk); Narrow news coverage limited to single export-license event; No insider/activist/legal/ESG data available; Speculative pre-revenue profile with high dilution risk
ACN — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: 44. Original rationale: Three of four committee members (Value, Bear, Macro) recommend Fail; the Growth analyst assigns Grey citing insufficient data for a growth thesis but does not rebut the negative signals. The quantitative evidence that does exist is uniformly adverse: Piotroski F‑score 1/9 (critical), Value score 2.92/10 (near‑bottom decile), current price $229.68 vs. Graham Number $127.17 (~81% above, implying negative margin of safety despite a reported 23.53% MoS that is mathematically inconsistent). Macro regime is risk_off with GPR at the 89.8th percentile, a headwind for discretionary IT services. The sole positive news item — an $8B acquisition push — is flagged by Bear and Macro as an integration/goodwill risk rather than a catalyst. No earnings, cash‑flow, balance‑sheet, or moat data are provided to offset these signals. The prior Grey verdict (conviction 0.40, MoS 34%) has not been validated; valuation buffer has narrowed and macro backdrop has worsened. The bear case is convergent and unrebutted.
Key Risks: Piotroski F‑score 1/9 signals broad deterioration in profitability, leverage, liquidity, and operating efficiency; Graham Number $127.17 vs. price $229.68 implies ~44% overvaluation; reported 23.53% margin of safety is inconsistent with these figures; Value score 2.92/10 indicates expensive screening across P/E, P/B, EV/EBITDA vs. peers and history; $8B acquisition program carries integration risk, goodwill inflation, and potential write‑downs; Macro risk_off regime with GPR 89.8th percentile geopolitical stress pressures consulting/outsourcing budgets; Severe data gaps: no revenue, EPS, FCF, debt/EBITDA, moat metrics, or accruals detail provided; No observable institutional accumulation, sector ETF flows, or insider buying to support price
CDT — HOLD
Verdict: Grey | Conviction: 0.40
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: 13. Original rationale: The investment decision is clouded by a significant conflict between extreme valuation metrics and poor fundamental indicators. While the Graham Number of 91349.9186 and a Margin of Safety of 99.92% suggest a massive undervaluation at the current price of 0.2351, these figures are not reconciled with the Piotroski F-score of 0, which indicates a total lack of financial strength. The Bear analyst correctly identifies that the lack of underlying data (EPS, book value, debt levels) makes it impossible to determine if the low price is a value opportunity or a value trap. Furthermore, the Macro analyst notes a ‘risk_off’ regime with a high GPR percentile (89.82%), adding a layer of macro uncertainty. The News digest was present but only provided a neutral sentiment of 0.0, offering no specific catalysts or warnings to tip the scale. Due to the conflicting signals and insufficient data to validate the valuation’s integrity, a Grey verdict is required.
Key Risks: Piotroski F-score of 0 indicates severe fundamental and operational weakness.; Lack of transparency in the calculation of the Graham Number and Margin of Safety.; Risk-off macro environment with high GPR percentile (89.82%).; Absence of flow data (13F, ETF flows) to confirm institutional interest or distribution.
ABUS — HOLD
Verdict: Grey | Conviction: 0.38
Rationale: Numeric guard triggered — verdict revised to Grey. Fabricated figure detected: 12.5. Original rationale: The evidence bundle shows a pre-revenue biotech trading at 4.22 with a Graham Number of 4.8236 (12.5% discount), but the Value analyst notes the Graham Number inputs (positive earnings and book value) are unverified and the Macro analyst states it is ill-suited for pre-revenue biotechs. The Piotroski F-score is 0/9 — the worst possible — and the Value score is 2.94/10, both acknowledged by all four analysts. No income statement, balance sheet, or cash-flow figures are provided, leaving cash burn, runway, dilution history, and accruals as ‘insufficient data’ per the Bear analyst. The macro regime is risk_off with geopolitical risk at the 89.8th percentile, a headwind for high-beta clinical-stage names. The news digest contains a single ‘Good’ headline citing a ‘$230M buyback’ and ‘Moderna cash’ that ‘de-risks the path to a potential HBV cure’; sentiment is +0.1. This headline provides a catalyst narrative but is unverified (no execution details, pricing, or deal terms) and deemed financially immaterial by the Bear analyst. The prior review (2026-10-09) also returned Grey with 0.4 conviction and explicitly noted ‘MoS 0%.’ With three analysts at Grey and one at Fail, the bear case (Piotroski 0, no financials, risk-off macro) is compelling and not rebutted, but the buyback/Moderna news prevents a definitive Fail. Substantial uncertainty and thin data warrant Grey with low conviction.
Key Risks: Piotroski F-score 0/9 indicating severe fundamental deterioration; Absence of core financial data (revenue, earnings, cash flow, balance sheet); Risk-off macro regime with GPR percentile 89.8; Unverified $230M buyback and Moderna deal terms; Pre-revenue binary clinical risk in HBV with no pipeline milestones provided; Prior margin of safety 0% per 2026-10-09 review
ABXL — HOLD
Verdict: Grey | Conviction: 0.35
Rationale: The evidence bundle contains only the current price (25.22), a value score of 0.0, a Piotroski F-score of 0, news sentiment of 0.0, a macro regime reading of risk_off with GPR percentile 89.82035928143712 and yield curve 0.42, and a prior review from 2026-10-09 showing Grey verdict with conviction 0.25 and MoS 0%. No sector classification, financial statements, revenue, earnings, cash flow, or balance sheet data are provided. Three analysts (Value, Bear, Macro) lean Fail based on the worst-possible quantitative scores and the hostile macro backdrop; the Growth analyst maintains Grey due to a complete absence of growth-relevant metrics. However, the lack of underlying fundamental data prevents verification of the scores or any margin-of-safety calculation. The news digest comprised a single article scored by headline_lexicon showing neutral sentiment (0.0), offering no directional catalyst. Given the thin evidence base, a Grey verdict with low conviction is warranted per the rule that insufficient data warrants Grey with note ‘insufficient data for a conviction call’.
Key Risks: Piotroski F-score 0/9 indicating failing fundamentals; Value score 0.0/10 implying extreme overvaluation or impairment; Margin of safety 0% per prior review; Risk-off macro regime with GPR percentile 89.82035928143712; No sector classification or financial statements provided; No revenue, earnings, cash flow, or balance sheet data; News digest limited to one article with neutral headline sentiment
BRK.B — HOLD
Verdict: Grey | Conviction: 0.35
Rationale: The analysis is inconclusive due to insufficient data for a conviction call. The evidence bundle provides a Piotroski F-score of 0 and a Value score of 0.0, which are significant quantitative red flags according to the Value and Bear analyses. While the macro data indicates a ‘risk_off’ regime with a GPR_pct of 89.82, which might favor a conglomerate, there is no specific financial data (revenue, debt, cash flow) or news sentiment (0.0) to provide a counter-balance or a clear directional signal. The News digest was present but showed neutral sentiment (0.0), and thus did not change the outlook.
Key Risks: Piotroski F-score of 0 indicates potential fundamental health issues or data gaps; Value score of 0.0 suggests no margin of safety; Lack of granular financial metrics (debt, margins, revenue) prevents a thorough valuation
CMPS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNEY — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNOB — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CNP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CODA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COGT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COLB — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
COR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPHC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPSH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CPT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRGO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRNC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRNT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CRTO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTHH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTNM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTRE — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CTS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CURI — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CVNA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CW — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CWD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CXDO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
CXM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DAIO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DBCA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DDC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DEA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DFIN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DGP — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DGXX — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DGZ — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DLPN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DLR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DPC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DRK — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DSM — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DUKU — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
DXC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ECCC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ECCU — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ECF — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ECOR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EE — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EEA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EGAN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EHC — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EIKN — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EJH — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ELVA — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ENSG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ENTG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EONR — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EPOW — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EPRT — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EQIX — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
ERAS — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EVER — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EVG — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EVOX — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EW — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
EXPD — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
FATE — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
FBIO — HOLD
Verdict: Grey | Conviction: 0.00
Rationale: Deferred — deadline reached; heuristic pass only, no memory available.
AEP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for AEP is rejected based on a lack of margin of safety and deteriorating fundamental indicators. The stock’s current price of 127.14 significantly exceeds the Graham Number of 87.4669, indicating a premium over conservative intrinsic value. This is compounded by a very low Value score of 1.67 and a Piotroski F-score of 1, which signals poor financial health and deteriorating fundamentals. The News digest showed neutral sentiment (0.0) across 7 articles, providing no positive catalysts to offset the poor valuation metrics. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, but this does not override the clear evidence of over-valuation and weak fundamentals. The prior review also confirmed a ‘Fail’ with 0.85 conviction and 0% margin of safety.
Key Risks: Significant over-valuation relative to Graham Number (127.14 vs 87.4669); Poor financial health as indicated by a Piotroski F-score of 1; Low Value score of 1.67/10; High macro-risk exposure (GPR percentile 89.82)
AERT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: AERT is identified as a classic ‘value trap.’ While the Margin of Safety is high (69.82%), this is heavily outweighed by the critically low Piotroski F-score of 1, which indicates severe fundamental deterioration in profitability and financial health. The ‘risk_off’ macro regime (GPR percentile 89.82) and the Industrials sector classification create a challenging environment for a stock with such poor quality metrics. The News Digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental decay. The prior review also confirmed a ‘Fail’ with high conviction (0.95), suggesting the issues are structural rather than transitory.
Key Risks: Piotroski F-score of 1 indicates extreme fundamental weakness; High risk of a ‘value trap’ where low price reflects deteriorating fundamentals; Unfavorable ‘risk_off’ macro regime for the Industrials sector; Low Value score (2.92) indicating poor market perception of quality
AES — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for AES is fundamentally undermined by a critical lack of financial health, as evidenced by a Piotroski F-score of 1. While the current price of 14.95 is below the Graham Number of 20.4039, the extremely low Value score of 2.26 indicates that the market does not view this as a high-quality value opportunity, but rather as a potential ‘value trap.’ The ‘risk_off’ macro regime (GPR_pct of 89.82) typically favors utilities, but this is negated by the deteriorating financial position and the lack of any positive sentiment or growth catalysts. The prior review also confirmed a ‘Fail’ with high conviction (0.95) and 0% Margin of Safety. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the poor fundamentals.
Key Risks: Critical financial deterioration (Piotroski F-score of 1); Low Value score (2.26) suggesting poor quality of underlying assets; Zero Margin of Safety (0%) as noted in prior review; Risk-off macro environment increasing scrutiny on debt and capital expenditure
AESP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a total lack of fundamental support and a highly unfavorable macro environment. The Piotroski F-score of 0 indicates a failure across all metrics of profitability, leverage, and operating efficiency. This is compounded by a Value score of 0.0 and a 0% Margin of Safety, meaning there is no valuation buffer. The macro environment is currently in a ‘risk_off’ regime with a GPR percentile of 89.82, which historically penalizes low-quality assets. The prior review also maintained a ‘Fail’ verdict with high conviction (0.95). No News digest was provided.
Key Risks: Piotroski F-score of 0 indicating systemic financial health failure; Zero Margin of Safety (0%); Risk-off macro regime with high GPR percentile (89.82); Lack of any quantifiable value or growth metrics
AEXA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a unanimous consensus across all committee members. The primary drivers are the extreme lack of fundamental health, evidenced by a Piotroski F-score of 0 and a Value score of 0.0, which indicates no margin of safety. Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which penalizes assets with weak fundamentals. The prior review also confirmed a ‘Fail’ verdict with a high conviction of 0.95, and no data was provided to rebut these concerns. No News digest was provided.
Key Risks: Piotroski F-score of 0 indicating severe financial distress or deteriorating fundamentals; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82); Consistent historical failure with high conviction (0.95)
AFJK — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The Piotroski F-score of 0 indicates a total failure across fundamental health metrics (profitability, leverage, liquidity, and operating efficiency), and the Value score of 0.0 confirms a complete lack of margin of safety. These internal failures are compounded by a ‘risk_off’ macro regime (GPR percentile 89.82035928143712), which typically penalizes assets with weak fundamentals. No news digest was provided. The prior review also confirmed a ‘Fail’ verdict with high conviction (0.9), suggesting these issues are structural rather than transient.
Key Risks: Piotroski F-score of 0 indicating extreme financial instability; Value score of 0.0 indicating zero margin of safety; Risk-off macro environment (GPR percentile 89.82) favoring high-quality assets; Lack of any positive data or flow signals to offset fundamental decay
AGIG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a consensus of extreme fundamental weakness. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a very low Value score of 1.25 and a ‘risk_off’ macro regime (GPR percentile of 89.82), which typically penalizes low-quality assets. The prior review also confirmed a ‘Fail’ verdict with 0.95 conviction. No news digest was provided.
Key Risks: Piotroski F-score of 0 indicating severe fundamental instability; Low Value score of 1.25 suggesting no margin of safety; Risk_off macro environment penalizing low-quality equities; Consistent historical ‘Fail’ verdict
AI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete lack of fundamental support and extreme valuation risks. The Piotroski F-score of 0 indicates a total absence of positive financial signals, while the Margin of Safety of -550.57% suggests the asset is priced at a massive premium over its intrinsic value. The News Digest highlighted a ‘Bad’ sentiment regarding a ‘Sell’ rating and a clear distinction between the ticker and its more favored competitor, Palantir. These factors, combined with a ‘risk_off’ macro regime (GPR percentile 89.82), make the investment unsuitable for the current environment. The prior review also confirmed a ‘Fail’ with high conviction.
Key Risks: Extreme overvaluation (Margin of Safety of -550.57%); Poor financial health (Piotroski F-score of 0); Competitive displacement and analyst downgrades; Unfavorable ‘risk_off’ macro environment
AIBZ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a catastrophic failure across all fundamental and quantitative metrics. The Piotroski F-score of 0 indicates a complete lack of financial health, and the Value score of 0.0 confirms no valuation support. Most critically, the Margin of Safety is -242.65%, suggesting the price of 2.33 is disconnected from any tangible asset base. These internal failures are compounded by a ‘risk_off’ macro regime (GPR_pct of 89.82) which is unfavorable for speculative technology stocks. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the structural risks. The consistency of the ‘Fail’ verdict in the prior review (conviction 0.95) reinforces the decision.
Key Risks: Extreme valuation disconnect (Margin of Safety of -242.65%); Critical financial distress (Piotroski F-score of 0); Unfavorable ‘risk_off’ macro environment; Lack of fundamental value or growth indicators
AIN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a catastrophic lack of margin of safety and deteriorating financial health. The Margin of Safety is -1952.7%, indicating the stock is priced at a massive premium over its intrinsic value. This is compounded by a Piotroski F-score of 1, signaling severe operational and financial weakness. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes the stock’s position in the Consumer Cyclical sector. The News digest confirmed these concerns, showing that the stock ‘Needs To Drop A Little Further Before Deserving An Upgrade,’ indicating a lack of immediate upside. The prior review also confirmed a ‘Fail’ verdict with high conviction (0.95) based on similar metrics.
Key Risks: Extreme overvaluation (Margin of Safety of -1952.7%); Poor financial health (Piotroski F-score of 1); Unfavorable macro environment (Risk-off regime, GPR > 80); Lack of analyst confidence (News digest indicates need for further price drop)
AIZN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a total failure of fundamental and quantitative guardrails. The Piotroski F-score is 0, indicating severe issues with profitability, leverage, and operational efficiency. The Value score is 0.0, and the prior review confirms a 0% Margin of Safety. Furthermore, the macro environment is ‘risk_off’ with a GPR percentile of 89.82, which historically favors capital preservation over speculative assets. No News digest was provided in the evidence bundle.
Key Risks: Piotroski F-score of 0 indicating fundamental health collapse; Value score of 0.0 indicating no margin of safety; Risk-off macro regime (GPR percentile 89.82) creating high volatility for speculative assets; Prior review conviction of 0.95 on a Fail verdict
AKR — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and valuation alignment. The Piotroski F-score of 1 is the lowest possible score, indicating severe systemic weaknesses in profitability, leverage, and liquidity. Furthermore, the current price of 18.59 significantly exceeds the Graham Number of 11.409, meaning the stock does not offer a margin of safety relative to its tangible asset base despite the reported 20.93% margin of safety figure. The ‘risk_off’ macro regime (GPR percentile of 89.82) further compounds the risk for a Real Estate asset with such poor fundamental metrics. The News digest showed a ‘Good’ sentiment regarding a BREEAM sustainability rating upgrade, but the committee consensus is that this is a cosmetic ESG win that does not offset the fundamental decay and the fact that the price is trading at a premium to the Graham Number.
Key Risks: Extremely low Piotroski F-score (1) indicating severe financial instability; Price (18.59) significantly exceeds the Graham Number (11.409); Risk-off macro environment with high GPR percentile (89.82%); Low Value Score (2.29) indicating poor valuation quality
ALGT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for ALGT is fundamentally weak across all committee analyses. The most critical red flag is the Piotroski F-score of 1, indicating severe issues with profitability, leverage, and operational efficiency. While a ‘Margin of Safety’ of 45.3% is cited, this is contradicted by the fact that the current price (66.98) is significantly higher than the Graham Number (41.4982), suggesting the stock is trading at a premium to its fundamental floor. The ‘risk_off’ macro regime (GPR percentile 89.82) creates a hostile environment for cyclical Industrials. The News digest showed a ‘Bad’ signal with Susquehanna lowering its price target, indicating a lack of institutional conviction. The prior review also resulted in a ‘Fail’ with high conviction (0.95), confirming the cyclical risks and poor fundamental health.
Key Risks: Extremely low Piotroski F-score of 1 indicating poor financial health; Current price (66.98) trading significantly above the Graham Number (41.4982); Risk-off macro regime (GPR percentile 89.82) penalizing cyclical Industrials; Negative analyst sentiment and lowered price targets; Low Value Score of 2.29
ALHC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a catastrophic Piotroski F-score of 1, which indicates severe fundamental weaknesses in profitability, operating efficiency, and balance sheet health. This is compounded by a significant valuation disconnect: the current price of 8.28 is more than 3.5x the Graham Number of 2.3392, suggesting the stock is trading at a heavy premium to its intrinsic value. The News Digest showed ‘bad’ sentiment as both UBS and TD Cowen lowered their price targets, indicating cooling institutional confidence. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes stocks with weak fundamentals. The 47.06% Margin of Safety is deemed a ‘mathematical mirage’ because it is calculated against a valuation model that fails to account for the deteriorating financial quality. The prior review also maintained a ‘Fail’ verdict with high conviction.
Key Risks: Extremely low Piotroski F-score (1) indicating systemic financial decay; Significant premium over the Graham Number (8.28 vs 2.3392); Risk-off macro regime with high GPR percentile (89.82%); Downward revisions in analyst price targets from UBS and TD Cowen
ALTG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for ALTG is fundamentally compromised by a critically low Piotroski F-score of 1, which indicates severe deterioration in financial health, profitability, and operational efficiency. While the Margin of Safety is high at 83.19%, the Bear and Value analyses correctly identify this as a ‘value trap’—where the low price is a reflection of fundamental decay rather than an undervalued opportunity. This is compounded by a ‘risk_off’ macro regime (GPR percentile 89.82) which typically penalizes low-quality industrial stocks. The News digest showed neutral sentiment (0.0) across 8 articles, providing no catalyst to offset the structural risks. The prior review also confirmed a ‘Fail’ verdict, and no new evidence has emerged to overturn this consensus.
Key Risks: Piotroski F-score of 1 indicates extreme financial instability and potential ‘value trap’ dynamics.; Risk-off macro environment (GPR percentile 89.82) creates a hostile environment for low-quality industrial assets.; Low Value Score (1.67) suggests the underlying business quality is poor.; Cyclical nature of the business and lack of positive news catalysts.
ALX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a confluence of severe fundamental and valuation risks. The stock is trading at a significant premium to its intrinsic value, with a Margin of Safety of -51.85% (Current price 233.66 vs. Graham Number of 180.4701). Financial health is critically weak as evidenced by a Piotroski F-score of 1, indicating deteriorating profitability and liquidity. The News Digest provided a ‘Bad’ signal, showing Piper Sandler maintained an ‘Underweight’ rating and lowered the price target to $192, which represents a significant downside from the current price. These factors are compounded by a ‘risk_off’ macro regime (GPR percentile 89.82) which typically penalizes high-risk assets like those in the Real Estate sector.
Key Risks: Extreme overvaluation with a negative Margin of Safety of -51.85%; Severe operational and financial decay (Piotroski F-score of 1); Institutional skepticism and downward price target revisions ($192); Adverse macro environment (risk_off regime)
AMBQ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete lack of fundamental support and a highly unfavorable macro environment. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0 and a 0% Margin of Safety. The ‘risk_off’ macro regime (GPR percentile of 89.82) creates a hostile environment for a stock with such weak fundamentals. The News digest contained 9 articles but showed a neutral sentiment of 0.0, providing no positive catalyst to offset the structural risks. The prior review also confirmed a ‘Fail’ verdict with 0.9 conviction.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Risk-off macro regime with high GPR percentile (89.82); Zero Margin of Safety (0%); Lack of fundamental data to support a growth thesis in the Technology sector
AMCX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a critical breakdown in fundamental quality, as evidenced by a Piotroski F-score of 1. While the Margin of Safety is mathematically high at 98.25%, the committee consensus identifies this as a ‘value trap’ where the discount is a reflection of severe financial distress rather than an attractive entry point. The low Value score of 2.92 and the ‘risk_off’ macro regime (GPR_pct of 89.82) further suggest that the market is pricing in significant risk. The News digest confirmed this bearish outlook, showing a ‘Bad’ sentiment from Morgan Stanley maintaining an ‘Underweight’ rating with a price target of $9, which is below the current price of $10.15. The prior review also confirmed a ‘Fail’ verdict with high conviction, indicating consistent fundamental weakness.
Key Risks: Critically low Piotroski F-score of 1 indicating financial distress; Risk-off macro environment with high GPR percentile; Institutional skepticism with Morgan Stanley price target of $9; Potential value trap where high margin of safety is driven by deteriorating fundamentals
AMGN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a severe lack of a margin of safety and poor fundamental health. The current price of 432.49 is significantly higher than the Graham Number of 88.4977, resulting in a negative Margin of Safety of -57.21%. This is compounded by a critically low Piotroski F-score of 1, indicating significant fundamental weaknesses. The macro environment is currently ‘risk_off’ (GPR percentile 89.82), which typically penalizes assets lacking a safety buffer. The News digest showed a ‘Bad’ sentiment regarding the biotech sector taking a breather, further weakening the case for a high-premium entry.
Key Risks: Extreme overvaluation relative to Graham Number (88.4977); Poor fundamental health (Piotroski F-score of 1); Negative Margin of Safety (-57.21%); Risk-off macro regime (GPR percentile 89.82)
AMX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critically low Piotroski F-score of 1, which indicates severe deterioration in profitability, liquidity, and operational efficiency. While a ‘Margin of Safety’ of 97.4% is noted, the Bear and Value analysts correctly identify this as a ‘mathematical illusion’ because the current price of 22.91 is significantly higher than the Graham Number of 15.8864, and the low Value Score of 3.54 suggests the market is pricing in substantial risk. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes companies with deteriorating fundamentals. The News digest showed a neutral sentiment of 0.0, providing no catalyst for a turnaround. The prior review also confirmed a ‘Fail’ with high conviction (0.90), indicating that the fundamental issues are systemic rather than transitory.
Key Risks: Piotroski F-score of 1 indicating extreme financial decay; Macro ‘risk_off’ regime with high GPR percentile (89.82); Price significantly exceeds Graham Number (22.91 vs 15.8864); Low Value Score (3.54) indicating market recognition of hidden risks
AOSL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The most critical factor is the Piotroski F-score of 0, indicating extreme fundamental weakness across profitability, leverage, and liquidity. This is compounded by a very low Value score of 1.25, suggesting no margin of safety. The News digest provided ‘bad’ signals, specifically noting that ‘Fair Value Falls’ and a price target reduction to $34 by Stifel, which reflects deteriorating market confidence. Furthermore, the macro environment is currently ‘risk_off’ (GPR percentile 89.82), which typically penalizes speculative technology stocks with poor fundamental metrics. The prior review also confirmed a ‘Fail’ with high conviction (0.95).
Key Risks: Piotroski F-score of 0 indicating severe fundamental decay; Low Value score of 1.25 indicating no margin of safety; Risk-off macro regime (GPR percentile 89.82) penalizing high-beta tech; Negative news sentiment (-0.175) and falling fair value reports
APG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of margin of safety (-55.5%) and a failing Piotroski F-score of 1, which indicates significant fundamental weakness. While the news digest showed a ‘Good’ headline regarding Q2 Earnings Outperformance in the construction and maintenance services sector, this positive sentiment is insufficient to overcome the structural valuation issues and the ‘risk_off’ macro regime (GPR percentile of 89.82). The bear case regarding the ‘value trap’ nature of the stock—priced for perfection despite poor fundamentals—is not rebutted by the growth or value analyses, which both acknowledged the poor metrics as sufficient grounds for a fail.
Key Risks: Extreme overvaluation with a -55.5% Margin of Safety; Poor financial health indicated by a Piotroski F-score of 1; Unfavorable ‘risk_off’ macro environment with high GPR percentile; Cyclical nature of the Industrial sector in a tightening environment
APOS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘Fail’ due to a complete lack of fundamental support and a highly unfavorable macro environment. The Piotroski F-score of 0 indicates severe financial distress or a total lack of positive financial trends, while the Value score of 0.0 confirms no margin of safety. These internal failures are compounded by a ‘risk_off’ macro regime (GPR_pct of 89.82), which typically penalizes low-quality assets. The News digest provided no sentiment to offset these factors, and the prior review maintained a ‘Fail’ verdict with high conviction (0.95).
Key Risks: Piotroski F-score of 0 indicating fundamental collapse; Value score of 0.0 providing no margin of safety; Risk-off macro environment with high GPR percentile; Historical ‘Fail’ verdict with high conviction
APPS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a combination of severe fundamental weaknesses and an unfavorable macro environment. The primary drivers for this decision are the Piotroski F-score of 1 (the lowest possible score), indicating significant issues with profitability, leverage, and liquidity, and a Margin of Safety of -133.74%, which indicates the stock is trading at a massive premium over its intrinsic value. These internal metrics are compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82) and news digest reports of inflation concerns and geopolitical tensions that specifically threaten growth-oriented technology stocks. While the news digest noted a 6% rally in the Ad-Tech cluster, this localized movement is insufficient to offset the systemic risks identified by the committee.
Key Risks: Extreme overvaluation with a Margin of Safety of -133.74%; Poor financial health indicated by a Piotroski F-score of 1; Macroeconomic ‘risk_off’ regime with high GPR percentile (89.82); Inflation and geopolitical tensions pressuring the technology sector
APUS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators and a total lack of supporting data. The Piotroski F-score of 0 indicates a complete failure of fundamental health metrics (profitability, liquidity, and efficiency), while the Value score of 0.0 confirms no margin of safety. These internal failures are compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82) and a neutral news sentiment (0.0). The News digest contained 8 articles but provided no positive sentiment to offset the deteriorating fundamentals. All committee members reached a ‘Fail’ consensus due to the lack of any measurable upside or safety metrics.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Value score of 0.0 indicating no margin of safety; Risk-off macro environment (GPR percentile 89.82) unfavorable for low-quality assets; Lack of any positive sentiment or news catalysts
ARBB — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental weakness, deteriorating profitability, and poor liquidity. While the Margin of Safety is high at 99.57%, the low Value score of 2.92 suggests a ‘value trap’ where the price is low due to fundamental decay rather than an attractive entry point. The ‘risk_off’ macro regime (GPR percentile 89.82) creates a hostile environment for the Technology sector, and the neutral News sentiment (0.0) provides no catalyst to offset the poor financial health and macro headwinds. All committee members reached a consensus on the ‘Fail’ verdict based on these factors.
Key Risks: Piotroski F-score of 1 indicates severe operational and financial distress; Low Value score of 2.92 suggests a potential value trap; Risk-off macro regime (GPR 89.82) creates headwinds for Technology stocks; Lack of positive news sentiment or catalysts
ARDC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a catastrophic lack of fundamental safety and value. The Piotroski F-score of 0 indicates that the company failed on every metric of financial health (profitability, liquidity, and solvency). This is compounded by a Margin of Safety of -214.96%, suggesting the stock is priced at a massive premium over its intrinsic value. The macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which typically penalizes low-quality assets. The News digest contained one article with a sentiment of 0.0, providing no positive catalyst to offset the deteriorating fundamentals.
Key Risks: Extreme overvaluation with a Margin of Safety of -214.96%; Critical failure of fundamental health metrics (Piotroski F-score of 0); Unfavorable ‘risk_off’ macro environment; Zero value score and lack of any positive growth indicators
ARE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical ‘value trap’ profile. While the Margin of Safety is high at 69.04%, this is heavily outweighed by a Piotroski F-score of 1, which indicates severe deterioration in profitability, liquidity, and operating efficiency. The Bear and Value analysts both identified this as a signal of a ‘falling knife’ or a ‘death spiral.’ Furthermore, the Macro analysis highlights a ‘risk_off’ regime (GPR percentile 89.82%) and a low Value score of 2.92, suggesting that the deep discount is a reflection of structural risks rather than a temporary mispricing. The News Digest showed neutral sentiment (0.0) across 8 articles, providing no catalyst to offset the fundamental deterioration.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Potential ‘value trap’ where high Margin of Safety (69.04%) masks failing fundamentals; Risk-off macro environment (GPR percentile 89.82%) creating headwinds for the Real Estate sector; Low Value score of 2.92 indicating poor market perception of intrinsic value
AROC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails across all committee dimensions due to a combination of poor valuation, weak fundamentals, and unfavorable macro conditions. The primary drivers for the ‘Fail’ verdict are the negative Margin of Safety of -24.88% (with the current price of 29.56 significantly exceeding the Graham Number of 19.2538) and the critically low Piotroski F-score of 1, which indicates deteriorating financial health and poor accounting quality. The News digest showed a ‘Good’ headline regarding a ‘Next Growth Phase,’ but this was insufficient to offset the structural risks. Furthermore, the ‘risk_off’ macro regime (GPR percentile of 89.82) makes the overvalued, low-quality asset particularly risky in the current environment.
Key Risks: Negative Margin of Safety (-24.88%); Critically low Piotroski F-score (1) indicating poor financial health; Risk-off macro environment (GPR percentile 89.82) penalizing speculative assets; Low Value score (1.67) indicating lack of intrinsic value
ARTC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete lack of fundamental support and a high-risk macro environment. The core metrics are critically poor: a Piotroski F-score of 0 indicates a failure across all fundamental health metrics (profitability, leverage, liquidity, and operating efficiency), and a Value score of 0.0 confirms a 0% Margin of Safety. These results are compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82), which is particularly challenging for the Financial Services sector. No news digest was provided in the evidence bundle.
Key Risks: Piotroski F-score of 0 indicating systemic financial weakness; Value score of 0.0 indicating no margin of safety; Risk-off macro environment (GPR percentile 89.82) creating headwinds for the Financial Services sector; Complete lack of positive fundamental data or growth indicators
ARTV — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates that the company fails on every metric of financial health (profitability, leverage, liquidity, and operating efficiency). This is compounded by a very low Value score of 1.25, suggesting a ‘value trap’ profile where the low price is a reflection of deteriorating fundamentals rather than an opportunity. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes assets lacking fundamental support. The News Digest showed neutral sentiment (0.0), providing no positive catalyst to offset the fundamental decay. All committee members reached a consensus on a ‘Fail’ verdict based on these factors.
Key Risks: Piotroski F-score of 0 indicating total failure of financial health metrics; Low Value score of 1.25 suggesting a value trap; Risk-off macro regime (GPR percentile 89.82) creating headwinds for weak assets; Lack of sufficient data to establish a margin of safety or growth trajectory
ATHR — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete lack of fundamental support and a hostile macro environment. The Piotroski F-score of 0 indicates a failure across all fundamental health metrics (profitability, leverage, liquidity, and operating efficiency), and the Value score of 0.0 confirms the absence of a margin of safety. These internal failures are compounded by a ‘risk_off’ macro regime with a high GPR percentile of 89.82, which typically penalizes speculative assets in the Technology sector. The News sentiment of 0.0 provides no catalyst to offset these risks. The News digest was present but contained no actionable information (sentiment 0.0), thus it did not change the negative outlook.
Key Risks: Piotroski F-score of 0 indicating extreme operational decay or financial instability; Value score of 0.0 providing no margin of safety; Risk-off macro regime with GPR percentile of 89.82; Lack of positive sentiment or growth catalysts in the Technology sector
ATOS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health indicators. The Piotroski F-score of 0 indicates that the company fails on every metric of financial health (profitability, leverage, liquidity, and operating efficiency). This is compounded by a very low Value score of 1.25, which the Bear analyst identifies as a potential ‘value trap’ or ‘falling knife.’ Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which penalizes low-quality assets. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the poor fundamentals. All committee members reached a ‘Fail’ consensus based on the lack of data to support a growth or value thesis and the clear signals of fundamental decay.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Risk-off macro environment (GPR percentile 89.82) favoring high-quality assets; Lack of any quantifiable metrics to support a margin of safety or growth trajectory; Potential ‘value trap’ indicated by the 1.25 Value score
ATR — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe valuation issues and poor financial health metrics. The stock is trading at 124.51, while the Graham Number is 71.7716, resulting in a Margin of Safety of -73.03%. This indicates a massive premium over intrinsic value. Furthermore, the Piotroski F-score of 1 (the lowest possible score) signals significant fundamental and operational weaknesses. The News Digest confirmed these concerns by highlighting ‘Bottom Line Pressures’ that are preventing an upgrade, suggesting that the company’s profitability is under stress. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes assets lacking a margin of safety.
Key Risks: Extreme overvaluation (Margin of Safety of -73.03%); Poor financial health (Piotroski F-score of 1); Bottom line pressures impacting profitability; Risk-off macro environment (GPR percentile 89.82)
AVX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and a high probability of a ‘value trap.’ While the Graham Number (240.2271) suggests a massive discount relative to the current price (4.44), this is heavily outweighed by a Piotroski F-score of 0, indicating a total failure across all metrics of profitability, liquidity, and operating efficiency. The News Digest provided a ‘Bad’ signal, specifically identifying the stock as one of the ‘Top 3 Risk Off Stocks That May Fall Off A Cliff This Month,’ which, combined with a ‘risk_off’ macro regime (GPR percentile 89.82), suggests significant structural decay or an imminent liquidity event. The low Value Score of 2.5 confirms that the market does not view the price as a safe margin of safety.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Potential ‘cliff’ event as highlighted in the News Digest; Risk-off macro environment with high GPR percentile (89.82); Value trap risk where low price reflects structural decay rather than undervaluation
AXGN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of fundamental support and extreme valuation risk. The Piotroski F-score of 1 indicates a critical failure in financial strength, profitability, and operational efficiency. This is compounded by a massive negative Margin of Safety of -547.1%, indicating the current price of 34.62 is significantly above the calculated intrinsic value. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes the asset’s profile, as speculative or fundamentally weak stocks are prone to heavy selling in such environments. The News digest showed neutral sentiment (0.0), providing no positive catalysts to offset the structural risks.
Key Risks: Extreme overvaluation with a Margin of Safety of -547.1%; Critical financial weakness indicated by a Piotroski F-score of 1; Macroeconomic ‘risk_off’ environment (GPR percentile 89.82) penalizing high-risk assets; Low Value score of 0.42 suggesting lack of durable competitive advantage
AXP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for AXP is fundamentally undermined by two critical, non-rebutted bear arguments. First, the Piotroski F-score of 1 is the lowest possible score, indicating severe weaknesses in profitability, leverage, and operational efficiency. Second, there is a massive valuation disconnect: the current price of 313.59 is more than double the Graham Number of 137.2264, suggesting the stock is trading at a significant premium over its intrinsic floor. While a Margin of Safety of 33.37% is reported, the Bear and Value analysts correctly identify this as potentially illusory given the low Value Score (1.67) and the extreme premium over the Graham Number. The ‘risk_off’ macro regime (GPR_pct of 89.82) further compounds the risk of holding a high-multiple asset with deteriorating fundamental health. The News Digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the structural risks.
Key Risks: Critically low Piotroski F-score (1) indicating poor financial health; Significant premium over the Graham Number (313.59 vs 137.2264); Low Value Score of 1.67; Macro risk-off environment (GPR_pct 89.82) penalizing weak fundamentals
AZN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a severe lack of margin of safety and poor fundamental quality. The Graham Number of 71.2606 compared to the current price of 165.41 results in a Margin of Safety of -191.21%, indicating the stock is trading at a massive premium over its intrinsic value. This is compounded by a Piotroski F-score of 1, which signifies significant underlying financial weakness or deteriorating profitability. The ‘risk_off’ macro regime (GPR_pct of 89.82) further increases the risk of a correction for a stock with such a high valuation premium. The News digest showed a ‘Bad’ headline questioning if the 14.6x Forward Earnings is a buying opportunity, reinforcing the concern that the current valuation is not well-supported by fundamentals.
Key Risks: Extreme overvaluation relative to Graham Number (-191.21% Margin of Safety); Severe fundamental weakness indicated by a Piotroski F-score of 1; Macroeconomic ‘risk_off’ environment (GPR_pct 89.82) making high-multiple stocks vulnerable; Low Value score of 1.67
BANL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the extreme deterioration of fundamental indicators. While the Margin of Safety is mathematically high at 99.3%, the Piotroski F-score of 1 (the lowest possible score) indicates severe financial distress, deteriorating profitability, and weak operational efficiency. This, combined with a low Value score of 2.92, strongly suggests a ‘value trap’ where the low price reflects fundamental decay rather than an attractive entry point. The ‘risk_off’ macro regime (GPR percentile of 89.82) further compounds the risk, as the market is currently penalizing low-quality, high-risk assets. No news digest was provided in the evidence bundle.
Key Risks: Piotroski F-score of 1 indicates extreme financial distress and potential for insolvency or restructuring.; High probability of a ‘Value Trap’ where the 99.3% Margin of Safety is a byproduct of deteriorating fundamentals.; Risk-off macro environment (GPR percentile 89.82) creates a hostile environment for low-quality assets.; Cyclical nature of the Energy sector combined with poor financial health provides no clear path to recovery.
BANX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a catastrophic Piotroski F-score of 0, which indicates the company fails on every fundamental metric regarding profitability, liquidity, and operational efficiency. While the price of 19.895 is below the Graham Number of 22.4866 (providing a 17.45% margin of safety), the Bear and Value analysts correctly identify this as a ‘value trap’ because the low Value score of 2.93 suggests the market is pricing in the severe fundamental decay. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, further penalizing low-quality assets. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the structural weaknesses.
Key Risks: Piotroski F-score of 0 indicating severe fundamental decay; Low Value score of 2.93 suggesting a value trap; Risk-off macro regime with high GPR percentile (89.82); Lack of positive news sentiment or catalysts
BBGI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of catastrophic fundamental indicators and an adverse macro environment. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is compounded by a very low Value score of 1.25, suggesting no margin of safety at the current price of 8.28. The macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which typically penalizes low-quality assets. The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the poor fundamentals. The bear case regarding the F-score of 0 and the lack of valuation support remains unrefuted by any evidence in the bundle.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Extremely low Value score of 1.25 suggesting no margin of safety; Risk-off macro environment with high GPR percentile (89.82); Lack of positive news sentiment or catalysts
BBNX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily driven by the Piotroski F-score of 0, which indicates a complete failure across fundamental health metrics (profitability, leverage, liquidity, and operating efficiency). This is corroborated by the Value score of 0.0, indicating no margin of safety. The ‘risk_off’ macro regime (GPR percentile of 89.82) further penalizes the stock as it lacks the fundamental strength to withstand a risk-averse environment. The News digest showed a sentiment of 0.0, indicating no positive catalysts to offset the deteriorating fundamentals. The Bear case regarding the F-score of 0 is not rebutted by any other evidence in the bundle.
Key Risks: Piotroski F-score of 0 indicates systemic financial decay; Value score of 0.0 suggests no margin of safety; Risk-off macro environment (GPR 89.82) favors capital preservation over distressed assets; Lack of any positive news sentiment or catalysts
BEN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a combination of severe fundamental decay and a lack of margin of safety. The Piotroski F-score of 1 is the lowest possible score, indicating significant concerns regarding profitability and financial health. Furthermore, the current price of 30.98 exceeds the Graham Number of 27.6585, meaning the stock lacks a margin of safety. The Value Score of 1.23 confirms that the market does not perceive a significant moat or premium justification. The News Digest showed ‘bad’ sentiment with a price target reduction from Barclays, and the ‘risk_off’ macro regime (GPR_pct of 89.82) creates an unfavorable environment for a firm with such weak fundamental indicators.
Key Risks: Extremely low Piotroski F-score (1) indicating fundamental decay; Price (30.98) exceeds the Graham Number (27.6585); Low Value Score (1.23) suggesting lack of competitive moat; Unfavorable ‘risk_off’ macro regime (GPR_pct 89.82)
BGMS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for BGMS is fundamentally broken across all dimensions. The most critical factor is the Piotroski F-score of 0, which indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is corroborated by a low Value score of 2.5 and a 0% Margin of Safety (MoS) noted in the prior review. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which poses a significant threat to cyclical industrial stocks with weak fundamentals. There is no evidence of a moat, growth, or any redeeming factor to offset the severe financial risks.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Low Value score (2.5) and 0% Margin of Safety; Unfavorable ‘risk_off’ macro regime (GPR percentile 89.82); Cyclical industrial sector exposure without a defined moat
BH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of extreme valuation risk and deteriorating fundamental health. The Margin of Safety is -92.33%, indicating the current price of 434.04 is significantly above intrinsic value. This is compounded by a Piotroski F-score of 1, signaling severe deterioration in financial health and profitability. The News Digest provided a ‘Good’ sentiment score of 0.15 but explicitly warned that ‘Growth Drivers Won’t Last,’ confirming that any current price appreciation is likely driven by unsustainable factors. Furthermore, the ‘risk_off’ macro regime (GPR_pct of 89.82) makes the high-risk, low-quality profile of BH particularly vulnerable to significant drawdowns.
Key Risks: Extreme negative Margin of Safety (-92.33%); Critically low Piotroski F-score (1) indicating poor financial health; Unsustainable growth drivers as identified in the news digest; Unfavorable ‘risk_off’ macro environment with high GPR percentile
BHB — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to the extreme deterioration of fundamental health as evidenced by a Piotroski F-score of 1. While the asset offers a 41.89% margin of safety relative to the Graham Number of 46.7398, the committee consensus identifies this as a ‘value trap.’ The low Value score of 2.79 and the ‘risk_off’ macro regime (GPR percentile of 89.82%) suggest that the price discount does not compensate for the high risk of operational failure or insolvency. The News digest showed a sentiment of 0.1012, which is largely neutral and provides no catalyst to offset the severe fundamental red flags.
Key Risks: Piotroski F-score of 1 indicates severe financial health deterioration and potential ‘zombie’ status.; Low Value score of 2.79 suggests poor underlying asset quality.; Risk-off macro environment (GPR percentile 89.82%) creates a high-risk environment for a distressed financial services ticker.; Potential for the 41.89% margin of safety to be a ‘mathematical mirage’ due to non-persistent earnings.
BHST — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a complete lack of fundamental support. The Piotroski F-score of 0 indicates a total failure across profitability, liquidity, and operating efficiency metrics. This is compounded by a Value score of 0.0, meaning no margin of safety exists. While the News digest showed a ‘Good’ signal regarding a buyback of up to 5% of shares, this is insufficient to offset the ‘risk_off’ macro environment (GPR percentile of 89.82) and the lack of any positive valuation metrics. The company is identified as a speculative trap with no fundamental floor.
Key Risks: Piotroski F-score of 0 indicates severe financial health issues; Value score of 0.0 indicates no inherent margin of safety; Risk-off macro regime (GPR percentile 89.82) creates high vulnerability for speculative assets; Lack of quantifiable growth metrics or competitive moat
BIRD — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘Value Trap’ due to a critical failure in fundamental health. The Piotroski F-score of 0 is a definitive red flag, indicating that the company fails on all basic metrics of liquidity, profitability, and operating efficiency. While a Margin of Safety of 22.39% exists, it is insufficient to offset the risk of a deteriorating business model, as evidenced by the low Value score of 2.5. Furthermore, the ‘risk_off’ macro regime (GPR_pct of 89.82) creates a hostile environment for a technology stock with such poor fundamentals. The News digest showed neutral sentiment (0.0), confirming the absence of any positive catalysts to counteract the deteriorating fundamentals.
Key Risks: Piotroski F-score of 0 indicating systemic financial distress; Low Value score of 2.5 suggesting a value trap; Risk-off macro environment (GPR_pct 89.82) penalizing weak fundamentals; Lack of positive news sentiment to offset fundamental decay
BIT — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a ‘perfect storm’ of negative indicators across all dimensions. The News digest explicitly highlighted a ‘Bad’ rating downgrade because the company is ‘Paying Out More Than It Earns,’ signaling a lack of sustainable capital. This is corroborated by a Piotroski F-score of 0 (the lowest possible score) and a Value score of 0.0. Furthermore, the Margin of Safety is -15.26%, meaning the current price of 11.1 is significantly above intrinsic value. These fundamental failures are compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82), which historically penalizes companies with poor financial health and no valuation cushion.
Key Risks: Negative Margin of Safety (-15.26%); Piotroski F-score of 0 indicating extreme financial weakness; Rating downgrade due to paying out more than earned; Risk-off macro environment (GPR percentile 89.82) penalizing weak assets
BIVI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a complete failure across profitability, liquidity, and operational efficiency. This is compounded by a very low Value score of 1.25, suggesting the asset is either fundamentally broken or severely overvalued relative to its quality. Furthermore, the macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which historically penalizes speculative, low-quality assets. The News digest was present but showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental risks.
Key Risks: Piotroski F-score of 0 indicating extreme financial instability; Low Value score of 1.25 suggesting lack of margin of safety; Risk-off macro regime (GPR_pct 89.82) creating headwinds for speculative assets; Lack of positive news sentiment or clear growth catalysts
BIXI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a complete lack of fundamental support and a high-risk macro environment. The Piotroski F-score of 0 indicates a failure across all fundamental health metrics (profitability, leverage, liquidity, and operating efficiency), while the Value score of 0.0 confirms the absence of a margin of safety. These internal failures are compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82), which suggests a high-stress environment where assets lacking structural integrity are likely to be sold off. No news digest was provided.
Key Risks: Piotroski F-score of 0 indicating deteriorating financial health; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive fundamental or flow indicators
BJRI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a severe disconnect between the market price and intrinsic value, coupled with deteriorating fundamental health. The Graham Number of 28.098 against a current price of 59.38 results in a significant negative Margin of Safety of -48.45%, indicating the stock is heavily overvalued. This is compounded by a Piotroski F-score of 1, which signals extreme financial weakness and poor operational trends. While the News Digest mentioned a ‘New Unit Growth Story’ suggesting the stock could be 21% undervalued, this narrative is directly contradicted by the quantitative metrics (Value Score of 1.67) and the ‘risk_off’ macro environment (GPR percentile of 89.82), which penalizes cyclical stocks with poor fundamental quality.
Key Risks: Extreme overvaluation (Margin of Safety of -48.45%); Critical financial health deterioration (Piotroski F-score of 1); Macroeconomic headwinds in a ‘risk_off’ regime (GPR percentile 89.82); Speculative growth narrative not supported by fundamental data
BKE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected based on a combination of severe fundamental deterioration and a lack of valuation cushion. The Piotroski F-score of 1 is a critical red flag, indicating the lowest possible level of financial health and operational efficiency. This is compounded by a negative Margin of Safety of -5.75%, with the current price of 46.5 significantly exceeding the Graham Number of 30.7116. Furthermore, the macro environment is currently ‘risk_off’ (GPR percentile of 89.82), which is historically unfavorable for ‘Consumer Cyclical’ stocks. The News Digest showed a neutral sentiment (0.0), providing no positive catalysts to offset the poor fundamental and valuation metrics.
Key Risks: Critically low Piotroski F-score of 1 indicating fundamental decay; Negative Margin of Safety (-5.75%) and premium to Graham Number; Unfavorable ‘risk_off’ macro regime for cyclical stocks; Lack of growth evidence or positive sentiment
BKSY — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘Fail’ due to a combination of critical fundamental failures and an adverse macro environment. The Piotroski F-score of 0 indicates a complete lack of fundamental health across profitability, leverage, and liquidity. This is compounded by a Value score of 0.0, meaning there is no measurable margin of safety. The ‘risk_off’ macro regime (GPR percentile of 89.82) creates a hostile environment for an Industrials ticker with such poor fundamentals. The News digest contained 7 articles but yielded a neutral sentiment of 0.0, providing no catalyst to offset the structural risks. The prior review also noted a 0% Margin of Safety.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Value score of 0.0 providing no margin of safety; Risk-off macro regime (GPR percentile 89.82) impacting industrial cyclicals; Lack of positive sentiment or institutional flow data to offset macro headwinds
BMGL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the Piotroski F-score of 0, which indicates a total failure across profitability, leverage, liquidity, and operating efficiency metrics. This is reinforced by a very low Value score of 1.25, suggesting the stock is a ‘value trap’ rather than a discounted asset. The macro environment is currently ‘risk_off’ (GPR percentile 89.82), which favors high-quality, stable assets, making a company with failing fundamentals and no clear margin of safety an inappropriate choice. The news digest showed a neutral sentiment of 0.0, providing no positive catalyst to offset the fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe fundamental deterioration; Value score of 1.25 suggesting a value trap; Risk-off macro environment penalizing low-quality assets; Lack of any positive sentiment or growth indicators
BMHL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental decay and extreme overvaluation. The Piotroski F-score of 0 indicates a total failure across all metrics of financial health, suggesting significant operational distress. Furthermore, the stock is trading at 3.62, which is more than 5x the Graham Number of 0.6967, providing zero margin of safety. The Value Score of 1.25 confirms a lack of perceived moat or value. These internal failures are compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82), which typically penalizes low-quality assets. No news digest was provided.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Significant overvaluation (Price 3.62 vs. Graham Number 0.6967); Low Value Score (1.25) suggesting no competitive moat; Unfavorable ‘risk_off’ macro regime
BMNP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The Piotroski F-score of 0 indicates a complete failure of fundamental health metrics (profitability, leverage, liquidity, and efficiency). This is compounded by a Value score of 0.0, meaning there is no margin of safety for the current price of 96.66. The News digest showed a ‘Bad’ sentiment regarding a ‘Downgrade’ and ‘Cashing Out’ of Bitmine Immersion, which aligns with the negative news sentiment score of -0.1333. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which is unfavorable for assets lacking fundamental support.
Key Risks: Piotroski F-score of 0 indicating severe financial weakness; Value score of 0.0 providing no margin of safety; Negative news sentiment (-0.1333) and explicit ‘Downgrade’ in news digest; Unfavorable ‘risk_off’ macro regime with GPR percentile of 89.82
BOLD — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a complete lack of positive indicators regarding profitability, leverage, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25, suggesting a lack of margin of safety. The macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which creates a hostile environment for assets with deteriorating fundamentals. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental risks. All committee members reached a consensus on a ‘Fail’ due to the ‘distressed’ profile of the ticker.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting no margin of safety; Risk-off macro regime (GPR_pct 89.82) penalizing low-quality assets; Lack of any positive growth or sentiment indicators
BOOM — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe ‘Value Trap’ profile. While the Margin of Safety is numerically high at 70.52%, this is critically undermined by a Piotroski F-score of 1, indicating extreme fundamental weakness and deteriorating profitability. The low Value score of 2.92 further confirms that the market does not attribute quality or a moat to the business. Additionally, the macro environment is currently in a ‘risk_off’ regime (GPR percentile 89.82), which is historically hostile to distressed industrial assets. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the fundamental decay. All committee members reached a consensus that the high margin of safety is a byproduct of a failing business model rather than an undervalued opportunity.
Key Risks: Piotroski F-score of 1 indicates severe fundamental decay and potential for a value trap.; Risk-off macro environment (GPR percentile 89.82) penalizes low-quality industrial assets.; Low Value score (2.92) suggests a lack of competitive advantage or moat.; Lack of positive news sentiment or catalysts to drive a turnaround.
BOXL — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health and quality. The Piotroski F-score of 0 indicates a total failure across profitability, leverage, liquidity, and operating efficiency, suggesting a ‘falling knife’ scenario. While the Margin of Safety is high (95.57%), the extremely low Value score (1.25) indicates this is a ‘value trap’ where the discount is a reflection of fundamental decay rather than an undervalued asset. Furthermore, the macro environment is ‘risk_off’ (GPR percentile 89.82), which is unfavorable for a Technology stock lacking any positive news sentiment (0.0) or fundamental quality. The News digest showed neutral sentiment, providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score (1.25) suggesting a value trap; Risk-off macro regime (GPR percentile 89.82) creating headwinds for the Technology sector; Lack of positive news sentiment or catalysts
BPYPO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health, as evidenced by a Piotroski F-score of 0. This score indicates a complete lack of positive indicators across profitability, leverage, liquidity, and operating efficiency. While the Graham Number of 30.9629 suggests a theoretical margin of safety of 60.3% against the current price of 15.0, the Bear and Value analysts correctly identify this as a ‘value trap’ where the mathematical discount is negated by the extreme risk of capital impairment. This risk is compounded by a ‘risk_off’ macro regime (GPR percentile 89.82) and a low Value Score of 2.5. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the deteriorating fundamentals. All committee members reached a consensus on a ‘Fail’ verdict based on the severe risk profile.
Key Risks: Piotroski F-score of 0 indicating systemic financial weakness; Risk-off macro environment with high GPR percentile (89.82); Low Value Score (2.5) suggesting market recognition of high risk; Potential for capital impairment in a high-stress macro environment
BRO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for BRO is fundamentally undermined by a critical failure in basic financial health metrics. The Piotroski F-score of 1 (the lowest possible score) indicates severe weaknesses in profitability, leverage, or operating efficiency. Furthermore, the current price of 69.4 significantly exceeds the Graham Number of 52.15, meaning the stock lacks a margin of safety relative to its intrinsic value. The News Digest showed mixed signals, with Wells Fargo lowering its price target to $68 (below the current price of 69.4), while Citizens maintained a higher target of $75; however, this analyst divergence does not offset the structural risks. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes assets with such weak fundamental scores, as they are prone to liquidation during periods of market stress.
Key Risks: Critically low Piotroski F-score of 1 indicating severe financial weakness; Current price (69.4) trading at a significant premium to the Graham Number (52.15); Risk_off macro regime (GPR 89.82) increasing volatility for low-quality assets; Low Value Score of 2.92 suggesting poor fundamental standing
BSM — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a catastrophic lack of margin of safety and deteriorating fundamental health. The current price of 15.03 is significantly higher than the Graham Number of 10.1584, resulting in a Margin of Safety of -90.98%. This is compounded by a Piotroski F-score of 1, which indicates severe deterioration in profitability, liquidity, and operating efficiency. While the News digest showed a ‘Good’ headline suggesting the stock could be 7% undervalued based on gas growth plans, this minor sentiment is mathematically overwhelmed by the -90.98% overvaluation and the ‘risk_off’ macro regime (GPR percentile of 89.82). The bear case regarding the ‘value trap’ nature of the stock—where a small positive news narrative masks structural decay—is not rebutted by any evidence in the bundle.
Key Risks: Extreme valuation gap (Margin of Safety of -90.98%); Weak fundamental health (Piotroski F-score of 1); Risk-off macro environment (GPR percentile of 89.82); High sensitivity to commodity price volatility in the Energy sector
BSP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental weakness and extreme overvaluation. The Piotroski F-score of 1 (the lowest possible score) indicates significant issues with profitability and financial stability. Furthermore, the Graham Number of 4.5531 compared to the current price of 47.07 results in a massive negative Margin of Safety of -94.5%, suggesting the stock is trading at a significant premium to its intrinsic value. The ‘risk_off’ macro regime (GPR percentile 89.82) provides a hostile environment for a high-valuation technology stock with such poor fundamental metrics. The News Digest showed a neutral sentiment of 0.0, providing no catalyst to offset these risks.
Key Risks: Extreme overvaluation (Margin of Safety of -94.5%); Poor financial health (Piotroski F-score of 1); Unfavorable macro environment (risk_off regime, GPR percentile 89.82); Low Value Score (0.42)
BTTC — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a catastrophic failure of fundamental health indicators. The Piotroski F-score of 0 indicates extreme financial distress or a lack of operational viability. This is compounded by a very low Value score of 1.25, suggesting the asset is a ‘value trap’ rather than a discounted opportunity. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which creates a hostile environment for assets with such weak fundamentals. The News sentiment of 0.0 and lack of sector data further indicate a lack of positive catalysts or institutional interest. The News digest showed neutral sentiment (0.0) across 3 articles, which did not provide any catalyst to offset the poor fundamental metrics.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Risk-off macro regime with high GPR percentile (89.82) penalizing low-quality assets; Lack of fundamental data (Sector, Revenue, Debt) preventing a Margin of Safety calculation; Potential ‘value trap’ status indicated by the 1.25 Value score
BTU — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a trifecta of fundamental, regulatory, and macro-economic headwinds. The primary driver is the Piotroski F-score of 1, which indicates severe fundamental weakness and deteriorating financial health. This is compounded by a very low Value score of 1.67, suggesting no margin of safety. The News Digest highlighted ‘Bad’ news regarding an ‘Imminent Danger’ order from the MSHA, which introduces significant regulatory and operational risk. Furthermore, the macro environment is currently ‘risk_off’ with a high GPR percentile (89.82%), making the stock’s poor fundamentals and lack of value particularly risky in the current climate. The News digest showed negative sentiment and a broader sell-off in the energy sector, which further reinforces the bearish outlook.
Key Risks: Extremely low Piotroski F-score (1) indicating poor financial health; Regulatory risk from MSHA ‘Imminent Danger’ order; Lack of margin of safety (Value score 1.67); Unfavorable ‘risk_off’ macro environment with high GPR percentile (89.82%); Sector-wide sell-off of peer companies
BURU — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a critical lack of fundamental health and an unfavorable macro environment. The Piotroski F-score of 0 is a definitive indicator of financial distress, signaling failure across profitability, liquidity, and operational efficiency. This is compounded by a very low Value score of 1.25 and a ‘risk_off’ macro regime (GPR_pct of 89.82), which typically penalizes speculative industrial equities. The News Digest showed a sentiment of 0.0, indicating no positive catalysts to offset the fundamental risks. The prior review also confirmed a 0% Margin of Safety, and all committee members agreed that the lack of data regarding debt, growth, or moat, combined with the ‘risk_off’ environment, precludes a positive conviction.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Risk-off macro environment with high GPR percentile (89.82); Lack of margin of safety (0% in prior review); Low value score (1.25) suggesting poor market perception of intrinsic value
BXP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to the critically low Piotroski F-score of 1, which indicates severe fundamental weaknesses in profitability, leverage, or liquidity. While the Margin of Safety is mathematically high at 37.61%, the low Value score of 1.67 suggests this ‘discount’ is a value trap caused by deteriorating fundamentals rather than an attractive entry point. This is exacerbated by a ‘risk_off’ macro regime (GPR percentile 89.82) which is particularly challenging for the Real Estate sector. The News digest showed a ‘Bad’ signal with Piper Sandler lowering their price target to $72, confirming a downward adjustment in growth expectations. The Bear’s argument regarding the disconnect between the Graham Number (36.7753) and the current price (59.2) is not rebutted by other members, confirming the stock is trading at a premium to its fundamental valuation despite the high MoS calculation.
Key Risks: Piotroski F-score of 1 indicates severe fundamental instability; Risk-off macro environment (GPR 89.82) creates headwinds for Real Estate; Low Value score (1.67) suggests the discount is a reflection of poor business quality; Price is trading at a premium to the Graham Number of 36.7753
BZAI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ based on a confluence of severe fundamental, legal, and macro risks. The News digest reported ‘Ugly’ conditions, specifically citing a guidance cut and DOJ subpoenas, which introduced significant legal and operational risk. These are corroborated by a Piotroski F-score of 0 (indicating total failure on financial health metrics) and a very low Value score of 1.25. Furthermore, the macro environment is ‘risk_off’ (GPR percentile of 89.82), which is unfavorable for speculative technology stocks. The bear case regarding DOJ subpoenas and guidance cuts remains unrefuted by any positive data in the bundle.
Key Risks: DOJ subpoenas and legal exposure; Guidance cut and Wall Street downgrades; Piotroski F-score of 0 indicating poor financial health; Risk-off macro environment (GPR percentile 89.82); Low value score (1.25) indicating lack of margin of safety
BZH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is a clear ‘Fail’ due to severe fundamental deterioration and a lack of any supporting bull case. The most critical data point is the Piotroski F-score of 0, which indicates a complete failure across profitability, leverage, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25, suggesting the current price of 33.45 is not supported by underlying fundamentals. Additionally, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which poses a significant headwind for a Consumer Cyclical stock. The news digest showed neutral sentiment (0.0), providing no positive catalysts to offset the fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe fundamental weakness; Low Value score of 1.25 suggesting no margin of safety; Risk-off macro regime (GPR percentile 89.82) impacting Consumer Cyclical sector; Lack of any verifiable growth metrics or positive sentiment
CAAP — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to the extreme structural risk identified by the Piotroski F-score of 1. While the News digest showed ‘Good’ sentiment regarding passenger growth, this top-line growth is not translating into fundamental health, as evidenced by the lowest possible F-score (1/9), indicating significant issues in profitability, liquidity, or operational efficiency. Furthermore, the current price of 25.09 sits above the Graham Number of 21.4453, suggesting that the 60.63% Margin of Safety is a mathematical artifact that fails to account for the deteriorating fundamentals. The ‘risk_off’ macro regime (GPR_pct of 89.82) further compounds the risk of a ‘value trap’ in a cyclical industrial asset. All committee members agreed on a ‘Fail’ verdict based on the disparity between the discount and the poor financial health.
Key Risks: Piotroski F-score of 1 indicates extreme financial fragility and deteriorating fundamentals.; Risk_off macro environment (GPR_pct 89.82) creates a hostile environment for cyclical industrial assets.; Potential ‘value trap’ where a high Margin of Safety is offset by poor operational health.; Current price (25.09) exceeds the Graham Number (21.4453), undermining the valuation thesis.
CABA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics. The Piotroski F-score of 0 indicates a complete lack of positive indicators across profitability, leverage, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25, suggesting the current price of 1.41 is not supported by intrinsic value. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes stocks with weak fundamentals. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe fundamental risks.
Key Risks: Piotroski F-score of 0 indicating severe fundamental distress; Low Value score of 1.25 suggesting significant overvaluation or lack of margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive sentiment or growth catalysts
CALY — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to severe fundamental deterioration and a lack of margin of safety. The Piotroski F-score of 1 (the lowest possible score) indicates significant weaknesses in profitability and financial stability. This is compounded by a Margin of Safety of -52.09%, which the committee members interpreted as a sign that the stock is not providing a sufficient buffer against its intrinsic risks. Furthermore, the ‘risk_off’ macro regime (GPR_pct of 89.82) creates a hostile environment for a Consumer Cyclical stock with such poor fundamental metrics. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicates severe fundamental weakness; Negative Margin of Safety of -52.09% suggests a ‘Value Trap’ profile; Risk-off macro regime (GPR_pct 89.82) creates headwinds for the Consumer Cyclical sector; Low Value Score of 2.09
CART — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality and a significant valuation gap. The Piotroski F-score of 1 is a severe red flag, indicating deteriorating financial health and poor operational efficiency. This is compounded by the fact that the current price of 49.83 is more than double the Graham Number of 20.2551, suggesting the stock is trading at a significant premium over its intrinsic floor. Furthermore, the macro environment is currently ‘risk_off’ (GPR percentile 89.82), which poses a significant headwind for the Consumer Cyclical sector. The News digest showed neutral sentiment (0.0), providing no positive catalyst to offset the poor fundamentals and unfavorable macro backdrop.
Key Risks: Critically low Piotroski F-score of 1 indicating poor financial health; Significant over-valuation relative to the Graham Number (49.83 vs 20.2551); Hostile ‘risk_off’ macro regime (GPR percentile 89.82) for the Consumer Cyclical sector; Low Value Score of 2.92
CASH — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to the extreme fundamental weakness indicated by a Piotroski F-score of 1. While the Graham calculation suggests a Margin of Safety of 87.36% (Price 72.93 vs. Graham Number 85.2997), all committee members agree that this is a ‘value trap.’ The low Value Score of 3.38 and the ‘risk_off’ macro regime (GPR_pct 89.82) suggest that the market is pricing in significant structural risks or deteriorating fundamentals. The News digest showed neutral sentiment (0.0) across 8 articles, which failed to provide any positive catalysts to offset the severe red flags in the financial health metrics.
Key Risks: Extreme fundamental decay (Piotroski F-score of 1); Potential value trap where low price reflects deteriorating business model; Risk-off macro environment (GPR_pct 89.82) penalizing low-quality assets; Low Value Score (3.38) indicating lack of competitive moat
CBRE — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe valuation disconnect and weak fundamental health indicators. The current price of 133.08 is significantly higher than the Graham Number of 53.3748, resulting in a negative Margin of Safety of -36.8%. This is compounded by a Piotroski F-score of 1, which indicates very poor financial health and deteriorating fundamentals. Furthermore, the macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which typically poses a headwind for high-multiple assets with no margin of safety. The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the fundamental and valuation risks.
Key Risks: Extreme overvaluation (Price of 133.08 vs. Graham Number of 53.3748); Critical financial weakness (Piotroski F-score of 1); Negative Margin of Safety (-36.8%); Unfavorable ‘risk_off’ macro regime (GPR_pct 89.82)
CCK — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a combination of severe fundamental deterioration and a significant valuation disconnect. The Piotroski F-score of 1 is a critical red flag, indicating extreme weakness in profitability and balance sheet health. This is compounded by the fact that the current price of 114.15 is significantly higher than the Graham Number of 64.5759, meaning the stock trades at a substantial premium to its intrinsic value. The News Digest showed ‘Bad’ sentiment regarding a price target reduction to $116 by UBS, which sits very close to the current price, suggesting limited upside. Furthermore, the ‘risk-off’ macro environment (GPR percentile 89.82) makes the thin Margin of Safety of 15.48% insufficient to justify a position in a cyclical stock with such poor fundamental metrics.
Key Risks: Critically low Piotroski F-score of 1 indicating severe operational/financial weakness; Significant premium over the Graham Number (114.15 vs 64.5759); Risk-off macro environment (GPR > 80) penalizing cyclical stocks with weak fundamentals; Narrow margin of safety (15.48%) in a volatile macro climate
CCO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a severe lack of fundamental quality and an inadequate margin of safety. The Piotroski F-score of 1 is a critical red flag, indicating significant deterioration in profitability, operating efficiency, and balance sheet strength. This is compounded by a very low Value score of 1.67, suggesting the asset lacks a durable moat or high-quality earnings. The Margin of Safety of 11.03% is insufficient to compensate for the high risk profile and the ‘risk_off’ macro environment (GPR percentile 89.82). The News digest showed a neutral sentiment (0.0), which did not provide any positive catalysts to offset the poor quantitative fundamentals. The transition from the previous ‘Grey’ verdict to ‘Fail’ is justified by the consistent consensus across all committees regarding the ‘value trap’ characteristics of the ticker.
Key Risks: Piotroski F-score of 1 indicating extreme fundamental weakness; Insufficient Margin of Safety (11.03%) for the risk profile; Low Value score (1.67) suggesting lack of competitive moat; Risk_off macro regime (GPR percentile 89.82) increasing sensitivity to systemic shocks
CDRO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a trifecta of severe fundamental and valuation risks. First, the Piotroski F-score of 1 indicates extreme weakness in profitability and financial stability. Second, the valuation is fundamentally broken: the current price of 9.45 is significantly higher than the Graham Number of 2.3497, resulting in a negative Margin of Safety of -20.69%. Third, the macro environment is ‘risk_off’ (GPR_pct of 89.82), which typically penalizes low-quality, high-risk assets like this one. There is no evidence of a moat or growth to justify the premium over the Graham value.
Key Risks: Extreme overvaluation (Price 9.45 vs. Graham Number 2.3497); Critical financial decay (Piotroski F-score of 1); Negative Margin of Safety (-20.69%); Unfavorable ‘risk_off’ macro regime
CELZ — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected primarily due to a critical failure in fundamental health metrics and a lack of any supporting value or growth indicators. The Piotroski F-score of 0 is a definitive red flag, indicating a total failure across profitability, leverage, liquidity, and operating efficiency. This is compounded by a very low Value score of 1.25, suggesting the asset is not perceived as a value play and lacks a margin of safety. The macro environment is currently ‘risk_off’ (GPR percentile of 89.82), which typically penalizes companies with weak fundamentals. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the severe structural risks.
Key Risks: Piotroski F-score of 0 indicating severe financial distress; Low Value score of 1.25 suggesting a value trap; Risk-off macro regime (GPR percentile 89.82) favoring capital preservation; Lack of any verifiable growth metrics or positive sentiment
CEPS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a complete lack of fundamental support and a severe valuation disconnect. The Piotroski F-score of 0 indicates a total breakdown in financial health (profitability, leverage, liquidity, and efficiency). Furthermore, the Value score is 0.0, and the current price of 10.1 is significantly higher than the Graham Number of 0.12, suggesting the stock is trading at a massive premium to its tangible assets. These failures are compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82), which typically penalizes low-quality assets. No News digest was provided.
Key Risks: Extreme valuation disconnect (Price 10.1 vs. Graham Number 0.12); Critical fundamental decay (Piotroski F-score of 0); Zero margin of safety (Value score of 0.0); Unfavorable macro environment (risk_off regime)
CEVA — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental decay and an extreme lack of valuation cushion. The Piotroski F-score of 1 indicates the company is failing nearly all primary metrics of financial health (profitability, leverage, and efficiency). This is compounded by a Margin of Safety of -701.75%, indicating the stock is priced at a massive premium to its intrinsic value. Furthermore, the macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically creates headwinds for high-risk technology stocks. The News digest showed neutral sentiment (0.0) and did not provide any catalyst to offset the poor fundamentals.
Key Risks: Extreme valuation gap (Margin of Safety of -701.75%); Critical financial health deterioration (Piotroski F-score of 1); Unfavorable ‘risk_off’ macro regime (GPR_pct 89.82); Lack of growth data or positive sentiment to support a bull case
CFND — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The Piotroski F-score of 0 indicates a total failure across all metrics of profitability, leverage, liquidity, and operating efficiency. This is compounded by a Value score of 0.0, indicating no margin of safety for the current price of 2.69. The macro environment is ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes low-quality assets in the Financial Services sector. The News digest contained 2 articles but showed neutral sentiment (0.0), providing no catalyst to offset the fundamental and macro headwinds.
Key Risks: Piotroski F-score of 0 indicating severe fundamental distress; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive growth or sentiment indicators
CHAI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ due to a consensus across all committee members regarding the severe deterioration of fundamental health. While the Margin of Safety is high at 93.3%, this is identified as a ‘value trap’ because it is underpinned by a critically low Piotroski F-score of 1 and a very low Value score of 1.67. These metrics indicate a high probability of insolvency or fundamental decay. Furthermore, the macro environment is currently ‘risk_off’ (GPR_pct of 89.82), which penalizes speculative, low-quality assets. The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the structural risks.
Key Risks: Critical financial distress indicated by a Piotroski F-score of 1; Low asset quality as evidenced by a Value score of 1.67; Risk-off macro environment (GPR_pct 89.82) creating headwinds for speculative assets; Potential value trap where high Margin of Safety is a byproduct of a collapsing share price
CHCO — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment case for CHCO is fundamentally undermined by severe quality issues and a lack of valuation safety. The primary driver for a ‘Fail’ verdict is the Piotroski F-score of 1, which indicates extreme fundamental weakness in profitability and liquidity. This is compounded by a very low Value score of 1.67, suggesting the market does not recognize a competitive moat. While the News Digest showed some positive sentiment (0.0944) regarding a ‘Dividend Hike’ and ‘Board Refresh,’ these are considered ‘soft’ metrics that do not offset the ‘hard’ data of the F-score. Furthermore, the current price of 141.69 sits significantly above the Graham Number of 108.8065, meaning the stock lacks a sufficient margin of safety in a ‘risk_off’ macro environment (GPR percentile 89.82). The consensus across all committees is that the stock is a ‘value trap’ where speculative news is masking fundamental decay.
Key Risks: Extreme fundamental weakness (Piotroski F-score of 1); Risk-off macro environment (GPR percentile 89.82) penalizing low-quality assets; Price premium over Graham Number (141.69 vs 108.8065) reducing margin of safety; Low Value Score (1.67) indicating lack of competitive moat
CHD — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a severe lack of valuation cushion and deteriorating fundamental quality. The current price of 104.53 is significantly higher than the Graham Number of 35.8764, resulting in a negative Margin of Safety of -53.45%. This is compounded by a Piotroski F-score of 1, which indicates significant fundamental weakness. The News Digest included a ‘Bad’ signal from Barclays, which maintained an ‘Underweight’ rating and lowered the price target to $83, confirming that the current price of 104.53 is unsupported by institutional analysts. While the ‘risk_off’ macro regime typically favors the Consumer Defensive sector, the specific internal metrics and the substantial gap between intrinsic value and market price outweigh these sector-wide tailwinds.
Key Risks: Extreme overvaluation (Margin of Safety of -53.45%); Poor fundamental health (Piotroski F-score of 1); Institutional underweighting and price target of $83 (Barclays); Risk-off macro environment making over-extended valuations vulnerable
CHSCN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to severe fundamental deterioration as evidenced by a Piotroski F-score of 1, which indicates poor financial health and operating efficiency. This is compounded by a very low Value score of 0.42, suggesting the asset is not priced as a value play. While the ‘Consumer Defensive’ sector and ‘risk_off’ macro regime (GPR_pct of 89.82) provide a theoretical defensive tailwind, these are insufficient to offset the internal financial decay and the 0% Margin of Safety identified in prior reviews. The News digest showed a slightly negative sentiment of -0.0461, further failing to provide a bullish catalyst.
Key Risks: Extreme financial weakness (Piotroski F-score of 1); Lack of margin of safety (0%); Poor valuation metrics (Value score of 0.42); Potential value trap due to deteriorating fundamentals
CHY — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a critical disconnect between the company’s fundamental health and its market valuation. The Piotroski F-score of 1 is a severe indicator of deteriorating financial health and poor operational quality. This is compounded by a Margin of Safety of -83.03%, which indicates the stock is trading at a massive premium relative to its intrinsic value (Graham Number of 34.3643 vs. current price of 11.11). While the News Digest showed a ‘Good’ headline regarding ‘Record Revenue’ for Q4 2026, this top-line growth is insufficient to offset the structural decay signaled by the F-score and the fact that the stock is in a ‘risk_off’ macro regime (GPR percentile 89.82), which typically penalizes assets with weak fundamentals and high valuation premiums.
Key Risks: Extremely low Piotroski F-score of 1 indicating poor financial health; Negative Margin of Safety of -83.03% suggesting significant overvaluation; Risk-off macro environment (GPR percentile 89.82) penalizing weak fundamentals; Discrepancy between ‘Record Revenue’ headlines and poor underlying financial metrics
CIX — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails due to a combination of severe fundamental decay and extreme overvaluation. The Piotroski F-score of 1 indicates the lowest possible level of financial health, suggesting significant issues in profitability and liquidity. This is compounded by a negative Margin of Safety of -58.58%, as the current price of 35.95 is significantly higher than the Graham Number of 21.6709. While the News digest showed some positive sentiment regarding ‘CompX Strength’ and ‘Kronos Recovery’, this is insufficient to offset the structural risks. Furthermore, the macro environment is in a ‘risk_off’ regime (GPR percentile 89.82), which typically penalizes high-risk, low-quality assets like CIX.
Key Risks: Extreme overvaluation (Price 35.95 vs. Graham Number 21.6709); Critical fundamental weakness (Piotroski F-score of 1); Negative Margin of Safety (-58.58%); Macro risk-off environment (GPR percentile 89.82)
CLFD — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a combination of severe fundamental weaknesses and a significant valuation gap. The Piotroski F-score of 1 (the lowest possible score) indicates severe issues with profitability, liquidity, or solvency. Furthermore, the stock is trading at 29.47, which is significantly above the Graham Number of 14.8234, resulting in a negative Margin of Safety of -7.95%. These factors are compounded by a ‘risk_off’ macro environment (GPR_pct of 89.82) which typically penalizes speculative tech assets. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the poor fundamentals.
Key Risks: Extremely low Piotroski F-score (1) indicating poor financial health; Negative Margin of Safety (-7.95%) due to price being nearly double the Graham Number; Risk-off macro regime (GPR_pct 89.82) unfavorable for tech sector; Low Value score (1.67)
CLGN — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a ‘perfect storm’ of negative indicators. The company failed to meet both top and bottom-line expectations significantly: Q2 Adj. EPS of $(1.69) missed the estimate by $(0.24), and Sales of $108.000K missed the $1.466M estimate by over 90%. These failures are compounded by a Piotroski F-score of 0 and a Value score of 0.0, indicating a complete lack of fundamental strength or margin of safety. The News digest confirmed these ‘Bad’ results, and the current ‘risk_off’ macro environment (GPR percentile 89.82) makes the speculative nature of the stock particularly risky. The news digest showed a significant disconnect between expectations and reality, reinforcing the bearish case.
Key Risks: Extreme revenue miss ($108.000K actual vs. $1.466M estimate); Piotroski F-score of 0 indicating poor financial health; Risk-off macro environment with high GPR percentile (89.82); Negative news sentiment (-0.0556) and zero value score
CLLS — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment decision is a ‘Fail’ primarily due to a critical, unrebutted bear case: the Piotroski F-score of 0. This score indicates a total failure across fundamental health metrics (profitability, liquidity, and operating efficiency), which the Bear analyst correctly identifies as a ‘distress’ signal. While the Margin of Safety is high at 95.92%, the extremely low Value score of 1.25 suggests this is a ‘value trap’ where the price is depressed due to fundamental decay rather than an undervalued opportunity. The ‘risk_off’ macro regime (GPR_pct: 89.82) further penalizes the investment, as capital preservation is prioritized over speculative plays in the healthcare sector. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the poor fundamentals.
Key Risks: Piotroski F-score of 0 indicating severe financial distress or operational failure; Value trap risk where high Margin of Safety (95.92%) is driven by poor asset quality (Value score 1.25); Risk-off macro environment (GPR_pct 89.82) making capital preservation difficult in low-quality assets; Lack of positive news sentiment or momentum
CMG — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment fails primarily due to a severe lack of margin of safety and deteriorating fundamental indicators. The current price of 29.89 is significantly higher than the Graham Number of 6.5231, resulting in a Margin of Safety of -96.9%. This is compounded by a critically low Piotroski F-score of 1, which indicates significant weaknesses in financial health or trends. While the News Digest showed positive analyst sentiment (Raymond James ‘Outperform’ and UBS ‘stronger growth in 2027’), these qualitative views do not offset the quantitative risks. Specifically, the ‘risk_off’ macro regime (GPR_pct of 89.82) makes the stock’s high premium and low Value Score (1.67) unsustainable. The news digest’s mention of ‘near-term sales pressures’ further aligns with the bearish view that the stock is priced for perfection.
Key Risks: Extreme valuation gap (Price 29.89 vs. Graham Number 6.5231); Critically low Piotroski F-score of 1 indicating deteriorating fundamentals; Negative Margin of Safety of -96.9%; Risk-off macro environment (GPR_pct 89.82) penalizing high-multiple cyclical stocks
CMI — SELL
Verdict: Fail | Conviction: 0.95
Rationale: The investment is rejected due to a severe lack of margin of safety and deteriorating fundamental health. The stock is trading at 531.33, while the Graham Number is 202.7106, resulting in a Margin of Safety of -90.73%. This extreme overvaluation is compounded by a Piotroski F-score of 1, indicating significant fundamental weakness and poor operational trends. The macro environment is currently ‘risk_off’ (GPR percentile 89.82), which typically penalizes overvalued assets in the Industrials sector. The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the significant valuation gap and poor quality scores.
Key Risks: Extreme overvaluation relative to Graham Number (-90.73% Margin of Safety); Critically low Piotroski F-score of 1 indicating poor financial health; Risk-off macro regime making high-premium industrials vulnerable; Lack of positive news sentiment or catalysts
ACVA — SELL
Verdict: Fail | Conviction: 0.93
Rationale: All four committee analyses unanimously recommend Fail. The evidence bundle shows profoundly negative fundamentals: Piotroski F-score of 1/9 (very weak financial health), value score of 0.42/10 (deep overvaluation), and margin of safety of -11566.67% (price vastly exceeds intrinsic value). The prior review (2026-10-09) also returned Fail with 0.92 conviction and MoS -11500%. Macro context is risk_off with Geopolitical Risk percentile 89.8 (>=80 threshold), a significant headwind for Consumer Cyclical sector. News digest (6 articles, headline_lexicon) showed neutral sentiment (0.0), providing no positive catalyst. No revenue, earnings, cash flow, debt, or growth metrics are available to offset the quantitative signals. The bear case is unrebutted across all dimensions.
Key Risks: Extreme negative margin of safety (-11566.67%) indicating massive overvaluation; Piotroski F-score of 1/9 signaling severe financial distress risk; Value score of 0.42/10 confirming fundamental overvaluation; Risk-off macro regime with GPR percentile 89.8 pressuring Consumer Cyclical; Absence of any positive fundamental data (revenue, earnings, cash flow, growth); Neutral news sentiment (0.0) offering no catalyst for re-rating; Prior high-conviction Fail (0.92) persisting across reviews
AFGE — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected due to a complete lack of fundamental support and a highly unfavorable macro environment. The Piotroski F-score of 0 indicates severe issues with financial health, profitability, and liquidity. This is compounded by a Value score of 0.0, meaning no margin of safety exists for the current price of 16.085. The macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82, which typically penalizes assets with weak fundamentals. The news digest showed neutral sentiment (0.0), providing no positive catalysts to offset the poor quantitative metrics. The prior review also maintained a ‘Fail’ verdict with high conviction.
Key Risks: Piotroski F-score of 0 indicating severe financial health deterioration; Value score of 0.0 indicating no margin of safety; Risk-off macro regime with high GPR percentile (89.82%); Lack of any positive fundamental or growth indicators
AFYA — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment decision is a ‘Fail’ primarily due to the catastrophic Piotroski F-score of 1, which indicates severe financial distress and deteriorating fundamentals. While the ‘News digest’ showed positive sentiment (specifically a JP Morgan upgrade to ‘Overweight’ with a $19 price target) and a high Margin of Safety of 89.1% relative to the Graham Number of 20.053, these are outweighed by the fundamental decay. The ‘risk_off’ macro regime (GPR percentile 89.82) further penalizes companies with weak financial health. The consensus across all committee members is that the stock represents a ‘value trap’ where superficial analyst upgrades do not offset the underlying operational and financial fragility.
Key Risks: Piotroski F-score of 1 indicates extreme financial distress and deteriorating profitability/liquidity.; Potential ‘value trap’ where the 89.1% Margin of Safety is a result of fundamental decay rather than undervaluation.; Risk-off macro environment (GPR percentile 89.82) penalizes companies with weak fundamental scores.; Discrepancy between positive analyst sentiment and poor underlying financial metrics.
BBWI — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality as evidenced by a Piotroski F-score of 1. While the Margin of Safety is high at 69.12%, the committee consensus identifies this as a ‘value trap’ where the low price is a reflection of deteriorating profitability and operational efficiency rather than an attractive entry point. This is further compounded by a ‘risk_off’ macro regime (GPR percentile of 89.82) which poses significant headwinds for a Consumer Cyclical stock. The News Digest showed some positive price action (8.7% surge), but this was deemed insufficient to offset the systemic risks and poor quality scores (Value score of 2.92).
Key Risks: Piotroski F-score of 1 indicating severe fundamental deterioration; Risk-off macro environment (GPR percentile 89.82) penalizing consumer cyclical stocks; Low Value score (2.92) suggesting the price does not compensate for poor quality; Potential value trap where high Margin of Safety masks structural business decline
BCSF — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to the Piotroski F-score of 1, which indicates extreme fundamental weakness and deteriorating financial health. While the Graham Number of 19.2611 suggests a mathematical margin of safety of 69.57% against the current price of 10.26, the committee consensus identifies this as a ‘value trap.’ The ‘risk_off’ macro regime (GPR_pct of 89.82) further compounds the risk, as the company’s poor internal fundamentals make it ill-suited for a high-stress environment. The News digest showed a neutral sentiment of 0.0, providing no catalyst to offset the structural risks.
Key Risks: Piotroski F-score of 1 indicates severe financial instability and potential ‘falling knife’ scenario; High risk of a ‘value trap’ where the 69.57% margin of safety is offset by deteriorating fundamentals; Unfavorable ‘risk_off’ macro environment (GPR_pct 89.82) penalizing low-quality assets; Lack of positive news sentiment or growth indicators
BF.A — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment case for BF.A is fundamentally undermined by a Piotroski F-score of 0 and a Value score of 0.0, indicating a complete lack of fundamental health and margin of safety. The News digest provided a clear warning that dividend growth depends on a recovery that has yet to materialize, which, when coupled with the ‘risk_off’ macro regime (GPR percentile 89.82), creates a high-risk profile. The bear case regarding the 0.0 F-score as a sign of deteriorating fundamentals is not rebutted by any evidence in the bundle. While the news digest mentioned ‘innovation’ as a sector tailwind, it does not provide enough quantitative data to offset the structural risks identified by the committee.
Key Risks: Piotroski F-score of 0 indicating poor financial health; Value score of 0.0 indicating no margin of safety; Dividend sustainability risk due to lack of economic recovery; Unfavorable ‘risk_off’ macro environment
BID — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to the critical failure of fundamental health metrics. The Piotroski F-score of 0 indicates a complete lack of positive signals regarding profitability, leverage, liquidity, and operating efficiency. This is compounded by a Value score of 0.0, suggesting no margin of safety. The macro environment is currently ‘risk_off’ with a GPR_pct of 89.82, which typically penalizes assets with weak fundamentals. The news sentiment is neutral (0.0), and there are no data points to support a growth thesis or a valuation moat. The News digest was present but showed neutral sentiment (0.0) and did not change the conviction of the failure.
Key Risks: Piotroski F-score of 0 indicating deteriorating financial health; Value score of 0.0 indicating no margin of safety; Risk-off macro regime (GPR_pct 89.82) penalizing weak assets; Lack of any positive growth or moat indicators
BSRR — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to a critical failure in fundamental quality. While the stock trades at a 34.41% discount to its Graham Number (46.8453), this ‘value’ is identified as a potential value trap. The Piotroski F-score of 1 is a severe red flag, indicating extreme weakness in profitability, liquidity, or operating efficiency. This is compounded by a mediocre Value score of 4.02 and a ‘risk_off’ macro environment (GPR percentile 88.82%). The News digest showed neutral sentiment (0.0), providing no catalyst to offset the deteriorating fundamentals. All committee members agreed on a ‘Fail’ verdict based on the high probability of structural decay.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Potential ‘Value Trap’ where low price reflects poor business quality; Risk-off macro environment with high GPR percentile (89.82%); Mediocre Value score of 4.02
CBFV — SELL
Verdict: Fail | Conviction: 0.90
Rationale: The investment is rejected primarily due to severe fundamental deterioration evidenced by a Piotroski F-score of 1, which indicates significant issues in profitability, liquidity, or operating efficiency. While a ‘Margin of Safety’ of 44.79% is reported, this is contradicted by the fact that the current price (37.55) exceeds the Graham Number (30.4314), suggesting the ‘safety’ is a mathematical artifact rather than a valuation discount. Furthermore, the extremely low Value score of 1.11 and the ‘risk_off’ macro regime (GPR_pct of 89.82) suggest a high-risk environment where the company’s weak fundamentals are unlikely to be supported by market tailwinds. The News digest showed neutral sentiment (0.0), providing no catalyst to offset the forensic red flags.
Key Risks: Piotroski F-score of 1 indicating severe financial health deterioration; Current price (37.55) exceeds the Graham Number (30.4314); Low Value score of 1.11 suggesting poor market perception of quality; Risk-off macro environment (GPR_pct 89.82) penalizing low-quality assets
AQST — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the extreme lack of fundamental stability and a hostile macro environment. The Piotroski F-score of 0 and a Value score of 0.0 indicate a complete absence of financial health and a margin of safety, respectively. While the News digest showed a ‘Good’ sentiment regarding the ‘FDA Acceptance Of Anaphylm Resubmission,’ this is a binary regulatory milestone that does not offset the structural weaknesses. Furthermore, the macro environment is currently ‘risk_off’ with a GPR percentile of 89.82, which typically penalizes speculative healthcare names. The combination of a ‘broken’ fundamental profile and a high-stress macro regime makes the investment a speculative gamble rather than a viable investment.
Key Risks: Piotroski F-score of 0 indicates extreme financial fragility and lack of profitability.; Value score of 0.0 confirms no margin of safety.; Risk-off macro regime with a GPR percentile of 89.82 creates a hostile environment for speculative assets.; Binary risk: The company’s viability is tied solely to a single FDA outcome.
ARWR — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a complete lack of fundamental support and significant clinical risk. The Piotroski F-score of 0 indicates a total failure of financial health metrics, and the Value score of 0.0 confirms the absence of a margin of safety. The News digest contained ‘Ugly’ (severe risk) flags regarding the ARO-MAPT interim results and the TRiM CNS Delivery Platform, which are the core components of the company’s pipeline. These risks are compounded by a ‘risk_off’ macro environment (GPR percentile of 89.82) and a negative news sentiment of -0.105. The news digest showed significant risks in the core pipeline, which, combined with the lack of any positive valuation metrics, makes the stock a high-risk speculative play with no fundamental floor.
Key Risks: Piotroski F-score of 0 indicating deteriorating financial health; Severe risk flags in the News Digest regarding ARO-MAPT and TRiM CNS Delivery Platform; Lack of margin of safety (Value Score 0.0); Unfavorable ‘risk_off’ macro environment (GPR percentile 89.82)
ASB — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the critical ‘Value Trap’ profile identified by both the Value and Bear committees. While the Graham Number of 43.4345 suggests a high Margin of Safety of 55.79% relative to the current price of 28.96, this is heavily undermined by a Piotroski F-score of 1. This score is a definitive indicator of deteriorating fundamental health and poor earnings quality. Furthermore, the low Value Score of 2.92 confirms that the market is pricing in significant risks that the Graham calculation fails to capture. The News digest showed a mix of ‘Good’ (High-Growth Dividend) and ‘Bad’ (Wells Fargo price target reduction to $35), but the downward revision by a major analyst, combined with the ‘risk_off’ macro regime (GPR_pct of 89.82), suggests that the current discount is a reflection of structural weakness rather than a temporary mispricing.
Key Risks: Extremely low Piotroski F-score (1) indicating severe fundamental deterioration; Low Value Score (2.92) suggesting a potential value trap; Risk-off macro environment with high GPR percentile (89.82%); Price target reduction by Wells Fargo to $35
ATTT — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical ‘value trap’ signal. While the current price (2.554) is significantly below the Graham Number (11.1979), this discrepancy is invalidated by a Piotroski F-score of 0, which indicates severe fundamental deterioration in profitability, liquidity, and operational health. The ‘risk_off’ macro regime (GPR_pct of 89.82) further compounds the risk, as the market is pricing in a high risk premium for a company with such poor financial indicators. The News Digest showed a neutral sentiment of 0.0, providing no catalyst to offset the fundamental decay. All committee members identified the combination of a zero F-score and a risk-off environment as a clear signal of a distressed asset rather than a value opportunity.
Key Risks: Piotroski F-score of 0 indicating extreme financial distress; Value trap risk where low price reflects fundamental decay; Risk-off macro environment (GPR_pct 89.82) penalizing weak fundamentals; Lack of positive sentiment or catalysts to drive a turnaround
AURA — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is a Fail based on a ‘perfect storm’ of negative fundamental indicators that are not rebutted by the available data. Specifically, the Piotroski F-score of 0 indicates a total failure in fundamental health metrics (profitability, leverage, liquidity, and operating efficiency). This is compounded by a Value score of 0.0 and a 0% Margin of Safety, meaning the stock lacks any valuation floor. Furthermore, the macro environment is currently in a ‘risk_off’ regime (GPR percentile of 89.82), which typically penalizes speculative or low-quality assets. While the Growth and Macro analysts suggested a ‘Grey’ verdict due to data gaps, the Bear and Value analyses provide a compelling, unrebutted case that the fundamental metrics (F-score 0, Value 0.0) constitute a definitive red flag for capital impairment.
Key Risks: Piotroski F-score of 0 indicating severe financial instability; Value score of 0.0 and 0% Margin of Safety; Risk-off macro regime (GPR percentile 89.82) increasing volatility risk; Lack of any positive fundamental metrics to offset the poor quantitative scores
BLK — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is a ‘Fail’ primarily due to a severe valuation disconnect and a complete failure of fundamental quality metrics. The stock is trading at 1134.38, which is significantly above its Graham Number of 606.0676, resulting in a Margin of Safety of -50.14%. This is compounded by a Piotroski F-score of 0, indicating a failure in fundamental health and quality. While the News digest showed a ‘Good’ headline regarding AI’s potential to offset debt concerns, this sentiment (0.025) is insufficient to offset the extreme valuation premium and the ‘risk_off’ macro regime (GPR percentile of 89.82%). The Bear case’s argument regarding the lack of margin of safety and the F-score of 0 remains unrebutted by the Growth or Macro analyses.
Key Risks: Extreme valuation gap (Price is ~188% of Graham Number); Piotroski F-score of 0 indicating poor fundamental quality; Risk_off macro environment with high GPR percentile (89.82%); Lack of margin of safety (-50.14%)
BOX — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical failure in fundamental health as evidenced by a Piotroski F-score of 1. This score indicates extreme deterioration in profitability, liquidity, or operating efficiency. While a Margin of Safety of 16.59% exists, the Bear and Value analyses indicate this is likely a ‘value trap’ given the low Value score of 2.92 and the ‘risk_off’ macro environment (GPR percentile of 89.82%). The News digest showed a neutral sentiment of 0.0, providing no positive catalysts to offset the structural risks. The combination of a deteriorating fundamental ‘engine’ and a macro environment that penalizes high-beta technology stocks makes the risk profile unacceptable.
Key Risks: Piotroski F-score of 1 indicates severe fundamental decay; Risk-off macro regime (GPR percentile 89.82%) creates headwinds for the Technology sector; Low Value score of 2.92 suggests the asset is not well-regarded relative to its risk profile; Potential ‘value trap’ where the 16.59% Margin of Safety is insufficient to compensate for deteriorating fundamentals
BVN — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is a Fail primarily driven by two critical, non-rebutted bear arguments: a Piotroski F-score of 1 and a Margin of Safety of -220.89%. The F-score of 1 indicates severe fundamental weakness and deteriorating financial health. The negative Margin of Safety suggests the stock is trading at a massive premium relative to its calculated intrinsic value (Graham Number of 41.0557 vs. Current Price of 30.42). While the News Digest showed positive sentiment regarding ‘Affordable Growth’ and ‘High Growth Momentum,’ these qualitative headlines are insufficient to overcome the quantitative red flags. Furthermore, the ‘risk_off’ macro regime (GPR percentile 89.82) makes the speculative nature of a mining play with such poor fundamental metrics highly risky.
Key Risks: Extreme valuation gap (Margin of Safety of -220.89%); Severe financial instability (Piotroski F-score of 1); Macroeconomic risk-off environment (GPR percentile 89.82); High sensitivity to commodity price volatility in the Basic Materials sector
BXMT — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a critical failure in fundamental quality metrics. The Piotroski F-score of 1 is a definitive red flag, indicating significant deterioration in financial health or operational quality. While the Margin of Safety is reported at 70.78%, this is contradicted by the fact that the current price (10.53) is significantly higher than the Graham Number (5.8671), suggesting a lack of true ‘value’ in the traditional sense. The News digest showed ‘bad’ sentiment regarding a lowered price target from Keefe, Bruyette & Woods, and the macro environment is currently ‘risk_off’ with a high GPR percentile of 89.82%, creating a difficult tailwind for the Real Estate sector. The combination of a failing F-score, a low Value score of 1.04, and a macro environment favoring risk-off assets justifies a Fail verdict.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Price (10.53) trades at a significant premium to the Graham Number (5.8671); Risk-off macro regime with high GPR percentile (89.82%); Lowered price target from Keefe, Bruyette & Woods
BZ — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the extreme deterioration of financial fundamentals as signaled by a Piotroski F-score of 1. This score serves as a critical ‘guardrail’ failure, suggesting that the reported ‘Strong Q2 Growth’ in the news digest may not be translating into a healthy balance sheet or sustainable operations. Furthermore, the current price of 16.74 is above the Graham Number of 15.975, meaning the stock lacks a traditional valuation buffer. While the news digest showed positive headlines regarding growth and shareholder returns, these are insufficient to offset the risk of a ‘value trap’ in a ‘risk_off’ macro environment (GPR percentile 89.82). The discrepancy between the high Margin of Safety (90.87%) and the abysmal F-score suggests the ‘safety’ is illusory, likely caused by deteriorating fundamentals rather than an attractive entry point.
Key Risks: Piotroski F-score of 1 indicates severe financial instability or deteriorating fundamentals; Risk-off macro environment with high GPR percentile (89.82) penalizing high-risk assets; Price (16.74) exceeds the Graham Number (15.975), removing a primary valuation safety net; Potential ‘value trap’ where growth is not supported by balance sheet health
CACI — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a severe disconnect between market price and fundamental value, coupled with poor financial health indicators. The current price of 614.31 is significantly higher than the Graham Number of 331.3233, resulting in a negative Margin of Safety of -29.3%. This is compounded by a Piotroski F-score of 1, the lowest possible score, which indicates significant weaknesses in profitability, leverage, or operating efficiency. While the News Digest showed a positive ‘Outperform’ rating and a $780 price target from Macquarie, this analyst sentiment does not mitigate the objective risk of a ‘risk_off’ macro regime (GPR_pct of 89.82%) and the lack of a margin of safety. The bear case regarding the valuation gap and poor financial integrity remains unrefuted by the provided evidence.
Key Risks: Extreme overvaluation relative to Graham Number (331.3233); Critically low Piotroski F-score of 1 indicating deteriorating financial health; Negative Margin of Safety (-29.3%); Risk-off macro environment (GPR_pct 89.82%) penalizing high-multiple stocks
CAE — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a ‘perfect storm’ of forensic red flags identified by the Bear and Value committees. The Piotroski F-score of 1 is the lowest possible score, indicating severe deterioration in financial health and earnings quality. This is compounded by a significant valuation disconnect: the current price of 24.15 is nearly double the Graham Number of 13.0833, meaning the reported 34.96% Margin of Safety is illusory as the stock trades at a massive premium to its fundamental value. Furthermore, the News digest revealed an ‘Ugly’ risk: a $38.25 million class action settlement, which introduces significant legal and governance risk. While the Growth analyst noted a potential for 38% earnings growth in the sector, this is insufficient to offset the combination of poor fundamental health, overvaluation, and active litigation.
Key Risks: Extremely low Piotroski F-score (1) indicating deteriorating financial health; Significant legal risk from a $38.25 million class action settlement; Overvaluation relative to the Graham Number (24.15 vs 13.0833); Risk-off macro environment with high GPR percentile (89.82%)
CAPL — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the extreme deterioration of fundamental health as evidenced by a Piotroski F-score of 1. While the Margin of Safety is numerically high at 40.62%, the concurrent Value score of only 1.67 suggests a ‘value trap’ where the discount is a reflection of poor earnings quality and deteriorating fundamentals rather than an attractive entry point. The ‘risk_off’ macro regime (GPR percentile 89.82) further compounds the risk for a cyclical Energy stock. The News Digest contained 6 articles with a sentiment of 0.0, which provided no positive catalysts to offset the severe fundamental red flags.
Key Risks: Piotroski F-score of 1 indicates severe financial distress or deteriorating profitability; Low Value score (1.67) suggests the discount is a value trap; Cyclicality of the Energy sector in a risk-off macro environment; Lack of institutional flow data or positive sentiment to support the valuation
CCC — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment fails primarily due to a severe disconnect between market price and fundamental value, compounded by poor financial health indicators. The current price of 7.61 is significantly higher than the Graham Number of 2.1791, and the Value score of 1.67 indicates the asset is not a value play. Crucially, the Piotroski F-score of 1 is a major red flag, signaling significant underlying fundamental weaknesses. While the News digest showed ‘Good’ news regarding ‘Advanced’ buyout talks with GTCR and Elliott, this is a speculative catalyst that does not offset the lack of a fundamental floor. The ‘Bad’ news from Barclays (lowering the price target to $7.75) confirms that even with buyout rumors, there is very little upside headroom. The narrow Margin of Safety of 10.15% and the ‘risk_off’ macro environment (GPR percentile 89.82) further increase the risk of a correction given the weak fundamentals.
Key Risks: Extreme valuation gap (Price 7.61 vs. Graham Number 2.1791); Critical financial health (Piotroski F-score of 1); Narrow Margin of Safety (10.15%); Risk-off macro environment with high GPR percentile (89.82%); Reliance on speculative buyout rumors rather than organic growth
CHSCL — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to the critical failure of fundamental health metrics. The Piotroski F-score of 1 (on a 0-9 scale) indicates a ‘catastrophic deterioration’ in profitability and financial stability, which is not rebutted by any other data point. While the ‘risk_off’ macro regime and ‘Consumer Defensive’ sector classification suggest a structural tailwind, these are insufficient to offset the internal decay of the business. The low Value score of 0.42 further indicates a lack of margin of safety. The News digest was present but showed only slightly negative sentiment (-0.0461), which is insufficient to provide a catalyst for a ‘Pass’ given the poor fundamentals.
Key Risks: Piotroski F-score of 1 indicates severe fundamental decay and poor financial health.; Low Value score of 0.42 suggests the stock is overvalued relative to its fundamentals.; Lack of specific data on debt, margins, or intrinsic value to support a value thesis.; Potential for rapid correction in a risk-off environment due to weak internal metrics.
CLPT — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a complete lack of fundamental support and significant clinical risk. The Piotroski F-score of 0 indicates severe fundamental weakness, and the Value score of 0.0 confirms the absence of a margin of safety. The News Digest reported a ‘Bad’ event: a 24% share price drop following the uniQure AMT-130 trial update, which signals high clinical and regulatory risk. Furthermore, the macro environment is ‘risk_off’ (GPR percentile of 89.82), which is unfavorable for speculative healthcare assets. The bear case regarding the ‘falling knife’ scenario from the trial update is not rebutted by any positive data in the bundle.
Key Risks: Clinical trial failure/setback (AMT-130 trial update); Extreme fundamental weakness (Piotroski F-score of 0); Lack of valuation floor (Value score of 0.0); Unfavorable ‘risk_off’ macro regime
CMCSA — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment decision is driven by a critical, non-rebutted bear signal: the Piotroski F-score of 1. This score indicates a severe breakdown in fundamental health, including profitability and liquidity. While the ‘Margin of Safety’ of 64.52% and the Graham Number of 42.0172 suggest a deep discount, the Bear analyst correctly identifies that the market is likely pricing in a ‘risk premium’ due to these deteriorating fundamentals. This is compounded by a ‘risk_off’ macro regime (GPR percentile 89.82), which creates a hostile environment for a company with such poor fundamental metrics. The News digest showed a neutral sentiment (0.0), providing no catalyst to offset the structural risks. The discrepancy between the high Graham Number and the current price (21.9) is interpreted as a ‘value trap’ rather than a bargain.
Key Risks: Piotroski F-score of 1 indicates severe fundamental deterioration; Risk_off macro regime with high GPR percentile (89.82); Potential ‘value trap’ where low price reflects fundamental decay; Lack of positive news sentiment to offset poor fundamentals
CMCT — SELL
Verdict: Fail | Conviction: 0.85
Rationale: The investment is rejected primarily due to a critical ‘Value Trap’ signal. While the ‘News digest’ showed a ‘Good’ sentiment with a ‘Buy’ upgrade, this is contradicted by the underlying fundamentals. Specifically, the Piotroski F-score of 0 is a definitive red flag indicating a failure across all metrics of profitability, leverage, liquidity, and operating efficiency. This, combined with a low Value score of 2.5, suggests that the high Margin of Safety of 98.45% is likely a reflection of fundamental decay rather than an attractive entry point. The ‘risk_off’ macro environment (GPR_pct of 89.82%) further increases the risk of holding a structurally weak asset in the Real Estate sector.
Key Risks: Piotroski F-score of 0 indicating severe fundamental and operational distress; Potential ‘Value Trap’ where high Margin of Safety masks terminal decline; Risk-off macro environment (GPR_pct 89.82%) favoring high-quality assets over distressed ones; Low Value score of 2.5 suggesting poor market perception of asset quality
ACRE — SELL
Verdict: Fail | Conviction: 0.80
Rationale: All four committee perspectives align on fundamental deterioration and macro hostility. The Piotroski F-score of 1/9 and value score of 1.67/10 indicate severe weakness across profitability, leverage, liquidity, and operating efficiency. The macro regime is risk_off with geopolitical risk at the 89.8th percentile (GPR ≥ 80 threshold triggered) and a flat yield curve (0.42%), a combination structurally hostile to leveraged commercial real estate. The sole catalyst — KBW maintaining Outperform but lowering its price target to $4.50 — is a negative revision signal; at the current $3.45 price the stock trades 23% below even the reduced target. The reported margin of safety of 27.82% is inconsistent with the fundamental scores and likely reflects a value trap. The prior review (2026-10-09) also returned Grey with conviction 0.35 and MoS 23%, showing no improvement. News sentiment is effectively neutral (0.025) based on only four articles. No flow, institutional accumulation, or rotation data offsets the bearish mosaic.
Key Risks: Piotroski F-score 1/9 signals severe fundamental deterioration; Value score 1.67/10 places ACRE in bottom decile on quality/valuation; Risk-off macro regime with GPR percentile 89.8 pressures CRE credit; Flat yield curve (0.42%) removes carry benefit for mortgage REITs; Analyst price target lowered to $4.50 (23% above current) indicates downgrading expectations; Margin of safety 27.82% likely unreliable given fundamental scores; Critical data gaps: no earnings quality, balance sheet health, intrinsic value anchors, or Altman Z-score
ABSI — SELL
Verdict: Fail | Conviction: 0.70
Rationale: Three of four committee members (Value, Bear, Macro) recommend Fail based on unambiguous quantitative red flags: Piotroski F‑score 0/9 (worst possible), Value score 0.0/10, prior Grey verdict with 0.15 conviction and 0% margin of safety, and a risk‑off macro regime with geopolitical risk percentile 89.8 and yield‑curve slope 0.42. The Growth analyst assigns Grey solely due to insufficient growth‑specific data (no revenue, R&D, pipeline metrics) but does not rebut the bearish quantitative screens. The news digest (7 articles, sentiment 0.0) shows neutral headline sentiment and minimal coverage, offering no catalytic offset. With no visible fundamental strength, institutional flow tailwinds, or positive macro backdrop, the stacked evidence supports a Fail verdict. Conviction is moderated by the absence of full financial statements, cap‑table history, and pipeline/regulatory details that would enable a forensic review.
Key Risks: Piotroski F‑score 0/9 indicating failure on all nine fundamental health tests; Value score 0.0/10 suggesting no measurable fundamental value or extreme over‑valuation; Risk‑off macro regime with GPR percentile 89.8, historically punitive for pre‑revenue biotechs; Prior review Grey verdict (conviction 0.15, MoS 0%) reflecting deep uncertainty; No income statement, balance sheet, or cash‑flow data to assess burn rate, dilution, or earnings quality; Neutral news sentiment (0.0) and only 7 articles, implying lack of positive catalysts; Absence of institutional/insider flow data, short interest, or peer comps
ADAMO — SELL
Verdict: Fail | Conviction: 0.65
Rationale: Two hard quantitative screens sit at their theoretical floors: Piotroski F-score 0/9 (worst possible) and Value score 0.0/10 (no detectable value). These are not rebutted by any positive fundamental, growth, or flow evidence — the Growth and Macro analysts cite only data gaps, not offsetting strengths. The macro backdrop is risk-off with GPR percentile 89.8 and yield curve 0.42, a headwind for low-quality names. Sector is unclassified, preventing peer context. The prior review returned Grey with conviction 0.2 and MoS 0%, consistent with no margin of safety. The news digest contained 1 article with sentiment 0.0 (headline_lexicon), a neutral but low-confidence signal that does not alter the negative assessment.
Key Risks: Piotroski F-score 0/9 indicating failure on all nine fundamental checks; Value score 0.0/10 showing no discernible value characteristics; Sector unclassified — transparency and benchmarking concerns; Macro regime risk_off with GPR percentile 89.8 (elevated geopolitical stress); No financial data provided (revenue, earnings, cash flow, balance sheet); Prior verdict Grey, conviction 0.2, MoS 0%
AEM — SELL
Verdict: Fail | Conviction: 0.65
Rationale: The quantitative guardrails are uniformly and severely negative: Value score 1.67/10, Piotroski F-score 1/9, Graham Number 121.8924 vs price 189.53 yielding a -30.28% margin of safety. These metrics appear verbatim in the evidence bundle and are not rebutted by any company-specific positive fundamentals (debt/EBITDA, interest coverage, earnings quality, moat data are all ‘insufficient data’). The macro regime (risk_off, GPR percentile 89.82) is theoretically supportive for gold, but the news digest — 9 articles with net sentiment -0.0389 — highlights a ‘Bad’ headline: ‘Gold Slump Is Masking a $20 Billion Miner Cash Pile,’ directly contradicting the gold-bull narrative. No flow data (ETF, 13F, rotation) confirm institutional support. The prior review (2026-10-09) also returned Grey with conviction 0.40 and MoS -26%, showing persistent overvaluation. The confluence of critically weak fundamentals, deep overvaluation vs a conservative intrinsic-value benchmark, and a commodity-price headwind noted in the news digest creates a high-probability downside case with no offsetting catalyst evidenced.
Key Risks: Piotroski F-score 1/9 signals severe fundamental deterioration across profitability, leverage, and operating efficiency; Margin of safety -30.28% (price 189.53 vs Graham Number 121.8924) indicates deep overvaluation; Value score 1.67/10 places AEM in bottom decile on combined valuation/quality/momentum; Geopolitical risk percentile 89.82 (well above 80 threshold) adds operational/jurisdictional uncertainty; News digest flags ‘Gold Slump’ headline undermining the primary revenue driver; Absence of confirming flow data (ETF, 13F, rotation) and insufficient data on balance-sheet health, earnings quality, and moat
ADAMH — SELL
Verdict: Fail | Conviction: 0.60
Rationale: Three of four committee members (Value, Bear, Macro) recommend Fail based on extremely weak fundamental metrics: Value score 1.67/10 and Piotroski F‑score 1/9, which signal severe financial deterioration and no margin of safety (prior MoS 0%). The Macro analyst adds that a risk_off regime with GPR percentile 89.82 creates a hostile backdrop for such a fragile profile. The Growth analyst assigns Grey solely due to insufficient growth data, not a positive thesis. The news digest shows neutral sentiment (0.0 across three articles), offering no catalyst to offset the negatives. Sector is unclassified, and no financial statements are provided, reinforcing opacity. The prior review was Grey with conviction 0.15, and the new macro reading plus unchanged poor scores push the assessment to Fail. Conviction is moderate given meaningful disagreement (one Grey) and partial evidence (thin financial data).
Key Risks: Piotroski F‑score 1/9 indicates acute profitability, leverage, liquidity, and efficiency deterioration; Value score 1.67/10 suggests severe valuation disconnect from measurable fundamentals; Macro risk_off regime with GPR percentile 89.82 amplifies funding and liquidity stress; Sector unclassified and missing financial statements create governance/transparency concerns; Prior verdict Grey with 0.15 conviction and 0% margin of safety shows persistent fundamental fragility